Next Article in Journal
Circadian Lighting Was Associated with a Reduction in the Number of Hospitalized Patients Experiencing Falls: A Retrospective Observational Study
Previous Article in Journal
Breastfeeding Self-Efficacy in Postpartum Woman
Previous Article in Special Issue
Investigating the Impact of Body Composition Analysis on Quality of Life and Anxiety–Depression in Adult Males with Chronic Obstructive Pulmonary Disease
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies

by
Gabriela Isabela Verga (Răuță)
1,2,*,†,
Alexia Anastasia Ștefania Baltă
1,3,
Diana-Andreea Ciortea
1,4,*,†,
Carmen Loredana Petrea (Cliveți)
1,2,
Mariana Șerban (Grădinaru)
2,
Mădălina Nicoleta Matei
1,2,
Gabriela Gurău
1,2,
Victoria-Cristina Șuța
5,6 and
Doina Carina Voinescu
1,3
1
Faculty of Medicine and Pharmacy, University “Dunărea de Jos” of Galati, 800008 Galati, Romania
2
Emergency Clinical Hospital for Children “Sf Ioan”, 800487 Galati, Romania
3
St. “Apostol Andrei” County Emergency Clinical Hospital, 800578 Galati, Romania
4
Emergency Clinical Hospital for Children “Maria Sklodowska Curie”, 041451 Bucharest, Romania
5
Faculty of Medicine, University Ovidius of Constanta, 900470 Constanta, Romania
6
St. “Apostol Andrei” County Emergency Clinical Hospital, 900591 Constanta, Romania
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work as the co-first author.
Healthcare 2025, 13(14), 1691; https://doi.org/10.3390/healthcare13141691
Submission received: 22 May 2025 / Revised: 7 July 2025 / Accepted: 10 July 2025 / Published: 14 July 2025
(This article belongs to the Special Issue Clinical Healthcare and Quality of Life of Chronically Ill Patients)

Abstract

Background and aims: Rheumatic diseases are chronic, progressive conditions associated with severe pain, joint damage, disability, and even death. Healthcare interventions play a critical role in symptom management, patient education, and adherence to treatment plans. This study evaluates the role of healthcare interventions in the management of patients with rheumatic diseases, focusing on pain management, functional rehabilitation, patient education, and multidisciplinary collaboration. In addition, barriers to optimal care and potential solutions, including digital health technologies, are explored. Materials and methods: We conducted a narrative review of the scientific literature. Studies published between 2014 and 2025 were selected from PubMed, Scopus, Web of Science, Elsevier, Springer, Frontiers, and Wiley Online Library. Key areas of review included nurse-led pain management, education programs, and the impact of interdisciplinary care on patient outcomes. Results: Nursing interventions significantly improve pain control, treatment adherence, and self-management skills in patients with rheumatic diseases. Multidisciplinary approaches improve functional rehabilitation and increase quality of life in patients with rheumatic conditions. However, barriers such as insufficient health care resources, lack of patient awareness, and disparities in the availability of services hinder effective care delivery. Conclusions: A structured, multidisciplinary approach integrating healthcare interventions, digital health solutions, and patient-centered education is essential to optimize the management of rheumatic diseases. Future research should focus on improving access to non-pharmacological therapies and standardizing healthcare protocols for better patient outcomes.

Graphical Abstract

1. Introduction

Rheumatic diseases encompass a wide range of chronic musculoskeletal and systemic conditions, including both inflammatory conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and spondyloarthritis, and degenerative diseases such as osteoarthritis [1,2,3,4,5]. Overall, these conditions represent a significant global burden, contributing to long-term disability, reduced quality of life, and increased healthcare costs [6,7,8,9].
While inflammatory rheumatic diseases involve immune-mediated synovial inflammation and systemic organ damage, non-inflammatory forms are driven by biomechanical stress and metabolic alterations. Regardless of etiology, patients often present with chronic pain, joint stiffness, fatigue, and functional limitations [10,11,12,13,14].
Disease progression is influenced by multiple factors, including genetic predisposition, environmental triggers (e.g., smoking, infections), metabolic status (e.g., obesity, insulin resistance), and behavioral patterns (e.g., physical inactivity, diet) [15,16,17,18,19,20]. In addition, systemic inflammation in rheumatic diseases has been linked to increased cardiovascular morbidity, endothelial dysfunction, and accelerated atherosclerosis [21,22,23,24,25].
Advances in pharmacologic therapy—such as DMARDs, biologic drugs (e.g., TNF-α and IL-6 inhibitors), corticosteroids, and JAK inhibitors—have improved disease control and patient survival [26,27,28,29,30]. However, optimal long-term management requires an integrated, patient-centered approach that takes into account clinical symptoms and psychosocial well-being. Under the circumstances, the role of the nurse has gained increasing recognition [31,32,33,34].
Nurses are uniquely positioned to provide ongoing support in the care of rheumatic diseases through structured education, promotion of self-management, pain control, monitoring adherence to treatment, and early detection of complications [35,36,37,38,39]. Evidence from observational studies and clinical trials suggests that nursing interventions improve patient-reported outcomes, physical function, and mental health while reducing disease activity and comorbidity risks [40,41,42,43,44,45,46].
The EULAR (European Alliance of Associations for Rheumatology) recommendations have emphasized the importance of multidisciplinary care and identified nursing as the cornerstone of effective management [47,48,49,50]. However, a consistent gap persists between the guidelines and their implementation in clinical practice, in part due to variation in training, institutional support, and lack of standardized protocols for nursing interventions [51,52,53,54].
In addition, rheumatic diseases often coexist with metabolic and micronutrient imbalances (e.g., vitamin D, folic acid, B12), which can exacerbate disease severity. Healthcare interventions incorporating dietary assessment, supplementation guidance, and interdisciplinary referral have shown promising results in mitigating these risks [55,56,57,58,59].
Additional factors—such as gut microbiota dysbiosis, systemic inflammation, and the role of extracellular vesicles—have emerged as contributors to both rheumatic pathology and cardiovascular complications [60,61,62,63]. These findings highlight the need for holistic care strategies that prioritize systemic health beyond joint symptoms.
In 2018, the EULAR recommendations were updated, emphasizing the role of the nurse as part of the healthcare team. The general principles support shared decision-making with the patient and describe the importance of providing evidence-based care [64]. The EULAR 2018 recommendations highlight the need to improve nurses’ practice and knowledge in terms of education, clinical skills, and work organization. To prevent the risk of a high workload that could influence the quality of care, the appropriate organization of care by nurses is fundamental [65,66,67].
In the last 10 years, the care of patients with rheumatic diseases has changed considerably due to the early initiation of treatment and close monitoring of disease activity until remission is achieved. Individualized approach to patients with rheumatic diseases provides a sense of security due to the broad spectrum of clinical symptoms, which affect patients’ quality of life [68,69,70].
The primary objective of this narrative review was to explore how health care interventions influence disease outcomes and quality of life in patients with rheumatic diseases, with a particular emphasis on comparing the effectiveness of these interventions and identifying promising alternatives for improving clinical outcomes and quality of life [71,72,73].
The review aimed to identify key areas in which healthcare actions improve patient outcomes and to highlight gaps or inconsistencies in existing practices [74,75]. In addition, the authors evaluated the role of nurses in multidisciplinary care teams, analyzing how interprofessional collaboration improves the management of patients with rheumatic conditions [76,77].
Another key objective was to explore how nursing approaches vary according to the type and severity of rheumatic disease and patient-specific factors [78,79].
The review also addressed barriers to effective care by nurses, including workforce shortages, limited access to specialized professionals, disparities in healthcare infrastructure, and patient-related challenges in adhering to treatment. Finally, the study examined the integration of emerging healthcare strategies such as digital health tools and patient education models [80,81].

2. Materials and Methods

This review was conducted as a narrative review, combining the methodological rigor of a systematic review with the narrative approach of synthesis. This method was chosen to allow a detailed exploration of a complex and interdisciplinary topic, including medical care, management of rheumatic patients, and multidisciplinary collaboration in rheumatology. The synthesis of results emphasizes not only the reported data but also the clinical implications, gaps in knowledge, and future research directions.
The literature was selected through a non-systematic search of databases PubMed, Scopus, Web of Science, Elsevier, Springer, Frontiers, and Wiley Online Library, covering the period from January 2014 to January 2025. Keywords such as “nursing interventions, rheumatic diseases, pain management, patient education, multidisciplinary care, functional rehabilitation, healthcare accessibility” were used. Inclusion criteria were peer-reviewed articles in English that focused on the role of nurses in managing rheumatic conditions. Editorials and articles unrelated to clinical nursing interventions were excluded.

2.1. Identification of the Research Problem

The central research question: How do nursing interventions influence the disease progression and quality of life of patients with rheumatic diseases, and which strategies are most effective for optimizing patient care?
The study examines nursing interventions and patient outcomes in the management of rheumatic diseases, comparing different models of care and analyzing their effectiveness in controlling pain, improving physical function, and increasing patient adherence to treatment.
It also assesses current challenges in rheumatology care as well as emerging strategies such as digital health solutions and patient-centered nursing models.
The review integrates multiple perspectives to improve patient understanding and management, including:
  • Evaluating the effectiveness of non-pharmacologic interventions such as physiotherapy, patient education, and psychological support.
  • The role of multidisciplinary collaboration, with regard to the interaction between nurses, rheumatologists, and rehabilitation specialists in developing personalized care plans.
  • The impact of nursing interventions on patient outcomes, highlighting how early assessments by nurses contribute to long-term disease management, the effectiveness of structured rehabilitation programs, and the role of ongoing patient education in preventing complications.
The review examines barriers in providing optimal care, such as limited access to specialized nurses, disparities in health system infrastructure, and patient-related factors that influence adherence to care plans.
Gaps in existing knowledge and challenges in integrating nursing interventions into routine rheumatologic practice are identified.
Future research directions are proposed for optimizing nursing strategies, improving interdisciplinary collaboration, and enhancing the quality of patient-centered care in the management of rheumatic diseases.

2.2. Identifying Relevant Articles

In order to answer the research questions, a search was performed in the following databases: PubMed, Scopus, Web of Science, Elsevier, Springer, Frontiers, and Wiley Online Library.
The main keywords used in the search were: nursing interventions, rheumatic diseases, pain management, patient education, multidisciplinary care, functional rehabilitation, and healthcare accessibility.
These terms were combined into structured search strings to maximize relevance and select high-quality studies.
Each database was searched using tailored search strategies to account for differences in indexing systems and search functions. In addition to standard keyword searches, the following methods were used:
  • Citation tracking—identifying additional relevant studies based on references cited in key articles.
  • Related article exploration—using built-in features in databases such as ‘Similar Articles’ in PubMed and the Scopus citation network to find studies closely related to the research topic.
This multi-layered approach provided a comprehensive dataset that included essential studies, reducing the risk of omission of essential research on nursing interventions in rheumatic disease care.
Only full English-language articles were included to ensure access to high-impact international studies published in prestigious peer-reviewed journals.
Only peer-reviewed studies were considered, prioritizing clinical trials evaluating the effectiveness of healthcare interventions in the management of rheumatic diseases, systematic reviews and meta-analyses providing a synthesis of existing research, observational studies examining the impact of healthcare on disease progression and quality of life of patients, qualitative studies exploring patients’ and nurses’ experiences in the management of rheumatic diseases.
Review articles were prioritized if they provided a comprehensive synthesis of existing data, while clinical trials were analyzed for their insights into nurse-led interventions, multidisciplinary care, and patient adherence to treatment plans.

2.3. Eligibility Criteria for Study Selection

2.3.1. Inclusion Criteria

The selected articles had to focus on the nursing process in the care of patients with rheumatic diseases, particularly in terms of patient assessment, nursing interventions, and multidisciplinary care strategies. Publications had to provide information on:
  • Nursing interventions including pain management, functional rehabilitation, patient education, and psychological support in the care of patients with rheumatic diseases.
  • Assessment strategies, such as standardized functional assessment tools, pain scales, and clinical assessment methods, are used by nurses to monitor disease progression.
  • Multidisciplinary collaboration that examines the role of nurses in interdisciplinary teams, including rheumatologists, physiotherapists, occupational therapists, and other health professionals.
  • Patient adherence and self-care strategies, exploring the impact of nurse-led interventions on improving treatment adherence and quality of life.
The review included original research articles, systematic reviews, meta-analyses, and clinical trials published in indexed, peer-reviewed journals, ensuring the inclusion of high-quality, evidence-based sources.

2.3.2. Exclusion Criteria

The following studies were excluded from the review:
  • Case reports that did not have wider applicability or did not provide sufficient data on healthcare interventions and patient outcomes.
  • Studies that focused exclusively on pharmacologic treatments without discussing the role of nursing care in the management of rheumatic diseases.
  • Articles that did not include original data or were published in non-peer-reviewed sources were excluded, ensuring that only high-quality, scientifically validated research was considered.

2.3.3. Selection Process

To guarantee relevance, methodological rigor, and the caliber of the final selection, all identified papers were assessed using predetermined inclusion and exclusion criteria. The last set of research offers a thorough summary of nursing procedures, encompassing patient evaluation, pain management, functional rehabilitation, and interprofessional teamwork.
The selection procedure consisted of two separate stages:
Phase 1: Screening of titles and abstracts—The titles and abstracts were screened to assess general relevance, with an emphasis on research that examined medical treatment, patient outcomes, and healthcare approaches for treating rheumatic illnesses. At this point, studies that did not specifically address these issues or that lacked real data from their own research were eliminated.
Phase 2: Complete Text Analysis—The remaining studies were subjected to a thorough full-text analysis, with a focus on research that:
  • Investigated the links between healthcare treatments and patient outcomes, as well as the significance of multidisciplinary teams in rheumatology treatment;
  • Talked about ways to educate patients and help them adhere to treatment plans for rheumatic conditions;
  • Investigated obstacles to efficient treatment, such as healthcare inequalities and resource constraints.
In order to verify that the selected studies were in accordance with the study goals, they were subjected to a comprehensive examination.

2.3.4. Limitations of the Study

Although this procedure was intended to be thorough, some restrictions must be acknowledged:
  • Exclusion of gray literature: Unindexed but important research, such as institutional reports and conference papers, may have been omitted.
  • Language limitations: Only studies published in English were included, which might exclude important work in other languages.
  • Limitations on database selection—Restricting searches to specific platforms (PubMed, Scopus, Web of Science, etc.) may have resulted in excluding studies from other sources.
  • Restricting the publication period (2014–2025)—While this guarantees the inclusion of current and relevant studies, it may have left out earlier fundamental research that may have offered historical context for the development of rheumatology healthcare treatments.

2.3.5. Screening Process and Inclusion Decisions

To ascertain relevance and methodological rigor, each study went through two levels of review.
During the abstract and headline screening stage, each document was evaluated by two separate reviewers to determine its relevance to the study question. At this point, studies that did not specifically address nursing interventions in treating rheumatic illnesses were omitted. Any differences between reviewers were settled through dialogue or, if necessary, by consulting a third reviewer.
Studies that passed the initial screening were subjected to thorough full-text analysis using established inclusion and exclusion criteria. Two independent reviewers examined each article, ensuring consistency and reducing bias. Disagreements in the selection of studies were discussed and solved, with input from a third reviewer as needed.

2.3.6. Data Collection Methods

Data extraction process
A standardized data extraction form was developed in Microsoft Excel, ensuring a consistent approach to collecting information from all included studies.
To maintain accuracy and reliability, data extraction was carried out by two independent reviewers. A third reviewer cross-checked the extracted data for completeness and correctness, resolving any discrepancies that arose.
Extracted data included details of study characteristics such as author, year, study design, sample size, and setting.
Specific nurse interventions were documented, covering areas such as pain management, functional rehabilitation, patient education and multidisciplinary care. Primary outcomes assessed included pain reduction, functional improvement, quality of life and adherence to treatment plans.
This rigorous and systematic approach ensured that study selection and data collection processes were transparent, reproducible, and methodologically sound.

3. Results

3.1. Overview of Selected Studies

A comprehensive and systematic search of seven major databases was meticulously carried out, producing a substantial pool of 101,220 results. This meticulous approach ensures the inclusivity of the review process and instills confidence in the thoroughness of our research.
After eliminating duplicate records (20,000) and studies excluded for reasons such as lack of relevance, incomplete data, or methodological limitations (80,502), 718 articles remained for selection.
During the initial screening phase, 525 records were meticulously excluded based on predefined criteria, primarily because they did not focus on medical care in rheumatic diseases. In the first phase of review, 193 studies were assessed for eligibility, with articles meticulously assessed for their relevance to nursing interventions (pain management, functional rehabilitation, patient education), multidisciplinary care (collaboration between nurses, rheumatologists, and therapists), patient adherence and self-care strategies in the management of rheumatic conditions.
In the second phase, the authors conducted a detailed assessment by applying stricter inclusion criteria concerning the effectiveness of healthcare interventions, their impact on patients’ quality of life, and barriers to accessing healthcare. We excluded studies that focused solely on pharmacologic treatments or lacked a thorough analysis of healthcare strategies.
The final selection, carefully curated from a large pool of studies, included 86 publications. These studies, published between 2014 and 2025, offer significant and valuable insights into various aspects of healthcare for rheumatic diseases. This meticulous selection process ensures the quality and relevance of the studies included in our review.
Key findings highlight the effectiveness of nurse-led interventions in pain management and functional recovery. Patient education is crucial for improving treatment adherence and disease management. This intervention empowers patients with knowledge and skills to manage their condition effectively, enhancing their quality of life.
Additionally, the importance of multidisciplinary collaboration in improving patient outcomes and the challenges and barriers to providing optimal care for patients with rheumatic diseases are emphasized.
These findings contribute to a comprehensive understanding of how nursing strategies influence the management and progression of rheumatic diseases. By integrating data from multiple medical disciplines, this approach offers insight into the impact of nursing care on patient outcomes, functional rehabilitation, and multidisciplinary collaboration.
The studies have been systematically reviewed and synthesized to assess the effectiveness of nursing interventions, patient adherence, and challenges within nursing care. They provide objective data and clinically relevant insights that deepen our understanding of the nursing process in managing rheumatic diseases.

3.2. Types of Nursing Interventions

Nursing interventions for patients with rheumatic diseases are diverse and multifaceted. They address the disease’s physical symptoms of disease and focus on the educational, functional, and psychosocial aspects. These interventions include educating patients about disease management and medication adherence, supporting self-care strategies, coordinating multidisciplinary care, and monitoring patient outcomes. They are based upon clinical experience and a growing body of evidence, making them an essential part of the patient’s treatment plan.
Table 1 presents the main types of health care interventions identified in the included studies, grouped according to the intervention objective and supported by key evidence.
Pain is at the heart of health care, particularly in rheumatic diseases, where chronic pain is a major cause of disability and reduced quality of life. Nurses have a key role in pain assessment and management by frequently assessing pain intensity using validated instruments, monitoring the effectiveness of treatment, and informing patients about pharmacological and non-pharmacological strategies such as exercise, relaxation methods, and cognitive-behavioral techniques. Effective pain control not only improves physical performance but also emotional state and compliance with therapy [81]. Pharmacologic approaches include the administration of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying anti-rheumatic drugs (DMARDs) to reduce inflammation and prevent joint damage [82,83]. However, concerns about long-term side effects such as gastrointestinal complications, osteoporosis, and immunosuppression require the integration of non-pharmacological methods [84,85]. These include heat and cold applications, paraffin therapy, acupuncture, and transcutaneous electrical nerve stimulation (TENS), which have demonstrated efficacy in reducing pain, stiffness, and improving the effects of medications [86,87].
The second major area is functional rehabilitation, which includes structured physiotherapy programs, guided exercise routines, and occupational therapy strategies aimed at maintaining joint mobility, increasing muscle strength, and preventing contractures or further disability [88,89]. Low-impact activities such as swimming, yoga and adapted physiotherapy are commonly recommended for patients with spondyloarthritis and osteoarthritis. The use of assistive devices, such as orthotics, orthotic insoles and ergonomic tools, further supports patients in daily tasks by reducing pressure on inflamed or weakened joints [90].
Patient education is another basic medical intervention. This focuses on self-management training, which includes instruction on medication adherence, symptom tracking, disease flare-ups, and lifestyle modifications [91]. Educational efforts are often provided through structured workshops, one-on-one consultations, or digital platforms such as mobile health apps for disease monitoring and goal setting [92]. In addition, nutritional counseling plays a supportive role in reducing systemic inflammation and weight management, particularly in rheumatoid arthritis and osteoarthritis. Evidence suggests that anti-inflammatory diets, including the Mediterranean diet and omega-3 fatty acid supplementation, may contribute to reduced disease activity and improved patient-reported outcomes [93].
The psychosocial support component of health care addresses the psychological burden of living with a chronic, often progressive illness. Counseling by nurses, referrals to mental health professionals, and support groups are commonly used strategies to improve emotional resilience and reduce the prevalence of depression and anxiety among rheumatic patients [94]. These interventions are particularly important as emotional distress is known to exacerbate disease activity and negatively affect adherence to treatment [95].
Overall, these various health care interventions form a multidimensional framework that supports both the physical and emotional health of people with rheumatic diseases, contributing to better long-term outcomes and improved quality of life (Figure 1).

3.3. Evidence of Effectiveness

Studies have consistently demonstrated the effectiveness of nurse-led interventions in improving health outcomes for patients with rheumatic diseases.
Table 2 presents the evidence on the effectiveness of nursing interventions in the care of patients with rheumatic diseases.
A systematic review by Melis et al. [96] found that tailored care for patients receiving biologic therapies resulted in better adherence to treatment and better disease management. Similarly, Alnaqbi et al. [97] highlighted the value of non-pharmacologic strategies implemented by nurses—such as supervised physical activity and lifestyle guidance—that led to improved joint function and reduced pain levels in patients with psoriatic arthritis.
Including psychological and emotional support in health care has also been linked to significant improvements in mental health outcomes. For example, cognitive-behavioral interventions provided by trained nurses helped to reduce anxiety, depressive symptoms, and fatigue in people with chronic inflammatory diseases [98]. These findings align with broader evidence on the role of exercise and patient education in alleviating disability and illness-related fatigue [99].
Nursing interventions promoting joint protection techniques and self-management education have been effective in increasing patient autonomy and adherence to treatment. According to Poh et al. [100], such educational strategies support better disease follow-up and empower patients to respond appropriately to symptom exacerbations.
A mixed-methods systematic review by Gavin et al. (2021) [101] discovered that interventions led by occupational therapists, frequently in collaboration with nurses, greatly enhanced self-management abilities in patients with rheumatoid arthritis, especially in fostering autonomy and adherence to treatment. In a similar vein, Bednarek et al. (2022) [102] highlighted that following EULAR recommendations is vital; nurse-led interventions based on these guidelines not only improved care quality but also raised patient satisfaction scores by as much as 30% in certain clinical environments. They observed differences in the consistency of implementation across institutions, which might affect results.
Incorporating rehabilitation-focused care was also demonstrated to meet the unmet needs of patients with comorbid conditions. Fedorchenko et al. (2020) [103] indicated that organized rehabilitation programs led by nurses enhanced patients’ functional independence (assessed with the Barthel Index) and decreased readmission rates by 18%. However, these programs demand considerable resource investment and cross-disciplinary collaboration, which may restrict scalability.
Valaas et al. (2019) [104] emphasized follow-up care as a key factor in adherence to self-management strategies; patients who had regular follow-up led by nurses demonstrated greater engagement and sustained long-term lifestyle changes more successfully than those lacking follow-up.
The rising adoption of digital health tools—typically implemented or overseen by nurses—has developed as an additional approach. Najm et al. (2023) [105] showed that digital interventions led by nurses, such as mobile applications and telemonitoring, resulted in better medication adherence and more regular symptom tracking. Nonetheless, gaps in digital literacy and access continue to be an issue, particularly for older individuals or those in socioeconomically disadvantaged groups.
In addition, interdisciplinary nurse-led models have demonstrated significant improvements in health-related quality of life. Auyezkhankyzy et al. [106] found that nurses’ involvement in interdisciplinary teams led to more personalized care, addressing both the physical and emotional domains of disease burden. This was echoed by Bednarek et al. [107], who emphasized that structured nurse-led consultations improve disease management and reduce patient anxiety.
Another essential but often overlooked aspect of rheumatology health care is advocacy. Nurses promote patients’ interests within interdisciplinary teams and the wider healthcare setting. This involves ensuring that referrals to rheumatologists, physiotherapists, or mental health experts are prompt, assisting with access to social services, and guiding patients in understanding insurance and disability benefits. In addition, nurses inform patients of their rights, enabling them to become involved in their care and make informed choices. In this advocacy role, nurses play a crucial role in connecting care and minimizing health inequalities, especially in marginalized communities [106].
Randomized trials, such as the ADIRA study [108], have demonstrated that nurse-guided dietary interventions can reduce inflammatory markers in rheumatoid arthritis, supporting the role of nutritional counseling in medical practice. Similarly, Raad et al. [109] confirmed that dietary adjustments combined with omega-3 supplementation—often promoted by nurses—were linked to reduced pain and stiffness.
Innovative nurse-led self-management interventions, such as the INSELMA model developed by Primdahl et al. [110], have further validated the importance of structured and interdisciplinary nursing strategies. These interventions contribute to sustained disease management, increased patient satisfaction, and improved quality of life.
Finally, the updated EULAR guidelines [111] provide strong support for an expanded role for nurses in rheumatology care. They state that nurses contribute significantly to initiating and maintaining evidence-based treatment plans with measurable effects on disease activity, patient education, and health system efficiency.

3.4. Comparative Analysis by Disease Type

Healthcare interventions in managing rheumatic diseases are increasingly personalized, reflecting pathophysiological complexity and clinical variability of different conditions. A comparative analysis reveals how personalized approaches enhance the effectiveness of care by addressing disease-specific problems.
Table 3 outlines disease-specific findings related to rheumatic conditions and highlights their corresponding nursing implications.
In rheumatoid polyarthritis (RA), which is characterized by chronic inflammation and joint destruction, nurses play a critical role in promoting joint protection strategies, providing education on early recognition of symptoms, and facilitating monitoring of disease-modifying treatments [112]. Recent updates of the EULAR emphasize structured patient education, support for self-management, and routine follow-up of disease activity as core responsibilities of nurses [113]. Advanced practice nurses also contribute to early flare detection and medication optimization, which are essential in preventing joint damage [114].
In osteoarthritis (OA), which usually involves mechanical degeneration of joints rather than autoimmunity, health care focuses on weight control, improving mobility, and reducing pain through physical therapy [115]. Interventions such as supervised exercise programs, ergonomic counseling, and support with assistive devices have been shown to improve stiffness and function [116]. Nurses have a key role to play in providing long-term lifestyle counseling targeting modifiable risk factors such as obesity and inactivity, particularly in older adults [117].
In systemic lupus erythematosus (SLE), a multisystem autoimmune disorder, medical care must take into account organ involvement, especially renal function, cardiovascular risk, and fatigue management [118]. Evidence supports the need for close monitoring of blood pressure, urinary protein levels, and psychosocial support, as SLE disproportionately affects women and young adults, often during peak reproductive years [119]. Nurses also provide sun protection education, adherence to immunosuppressive therapy, and reproductive counseling, which are essential in managing crises and preventing complications [120].
When addressing spondyloarthritis (SpA), particularly ankylosing spondylitis, the focus is on postural correction, spinal mobility exercises, and support for biologic therapies [121]. Nurses contribute to early detection, especially in young men with chronic back pain, and facilitate access to rheumatologic care [122].
In psoriatic arthritis, where cutaneous and joint symptoms coexist, nurses are involved in symptom management across multiple domains, often integrating dermatologic and rheumatologic protocols [123]. Education on the side effects of medications, particularly for biologic therapies, and the psychosocial burden of visible skin disease are also important aspects of care [124].
Finally, in juvenile idiopathic arthritis (JIA), which affects children and adolescents, medical care includes age-specific pain assessment, support for school integration, and coordination with pediatric specialists. Particular attention is given to family education and emotional support, as the disease often affects the entire household dynamic [125]. Nurses also advocate for transitional care planning to support adolescents as they transition to adult health services [126].

3.5. Multidisciplinary Collaboration

The effective management of rheumatic diseases relies heavily on multidisciplinary collaboration, with nurses playing a central coordinating role alongside rheumatologists, physiotherapists, occupational therapists, psychologists, dieticians, and social workers.
This integrated approach enables comprehensive care that extends beyond medical treatment and addresses the functional, emotional, and social dimensions of the patient’s experience [127].
In this context, nurses help to educate patients about the course of the disease, monitor responses to treatment, and encourage adherence to medication regimens. Their continuous presence in the clinical setting makes them essential in detecting early signs of disease exacerbation and facilitating timely interventions [128]. When nurses work together with rheumatologists, it becomes possible to optimize drug therapy and implement early adjustments of disease-modifying medications, reducing the likelihood of long-term complications [129].
Physiotherapists and occupational therapists are key partners in multidisciplinary teams. Their collaboration with nurses supports the restoration of mobility, functional independence, and the use of assistive devices that reduce stress on affected joints. This combined input improves patients’ commitment to rehabilitation and reduces the risk of further disability [130,131,132].
Psychologists contribute to the team by addressing the psychological burden often associated with chronic rheumatic conditions. Nurses who identify signs of emotional distress can ensure timely referral to mental health specialists. Such coordination is vital, as untreated depression or anxiety can reduce adherence to treatment and worsen disease outcomes [133,134].
Nutritional guidance also plays an important role. Dietitians and nurses work together to support anti-inflammatory eating habits, helping patients manage fatigue, weight and comorbid conditions. Patients benefit from structured, realistic meal plans that align with medical advice and cultural preferences [135].
Social workers complement the care team by assisting patients in accessing community resources, healthcare entitlements, and emotional support services. Nurses, being in close contact with patients, can alert social workers to problems related to financial issues, distress, or inadequate support at home, ensuring that patients receive comprehensive psychosocial care [136,137].
The value of this multidisciplinary collaboration has been consistently demonstrated in the literature. Patient-centered care that integrates medical, functional, and psychosocial elements is associated with improved health-related quality of life, increased satisfaction with care, and better outcomes in disease management [138,139,140].
Despite these benefits, several barriers remain. Fragmentation of services, insufficient interdisciplinary training and lack of formal structures for communication between team members can prevent collaborative care from reaching its full potential. In some settings, nurses are not always skilled or trained to take on active coordinating roles, and a shortage of specialized professionals, particularly in rural areas, may limit access to multidisciplinary support [141,142].
Emerging models of care suggest that nurse-led case management within multidisciplinary teams increases efficiency and continuity of care. These models have demonstrated reductions in hospitalizations and improvements in self-management among patients with complex rheumatic conditions [143,144]. At the same time, educational reforms and policies that promote nurse autonomy and team-based care are essential to support this development [145,146].
Continued investment in multidisciplinary collaboration, particularly in strengthening the role of nurses, is essential for the future of rheumatologic care. As the complexity of disease presentations increases, so does the need for integrated models of care that support the whole person, not just the disease [147].

3.6. Barriers to Implementation

Despite the proven effectiveness of healthcare interventions in the management of rheumatic diseases, their implementation in clinical practice is often constrained by multiple barriers. One of the most pressing problems is the limited access to specialized rheumatology care, particularly in rural or underserved regions. Patients in these areas frequently face delays in diagnosis and initiation of treatment, which can lead to disease progression and irreversible joint damage. This challenge is compounded by the lack of structured referral systems and poor integration between primary and specialized services [148,149].
Financial constraints are a critical obstacle for many patients, particularly in low- and middle-income countries where comprehensive insurance coverage is lacking or insufficient. The high cost of biological therapies, diagnostic imaging, and regular consultations can be prohibitive, often forcing patients to choose between essential needs and medical care [150,151]. Disparity in access to affordable care contributes to inequalities in adherence and long-term outcomes [152].
Another major barrier is the shortage of specialized rheumatology nurses. The complexity of managing chronic autoimmune conditions requires specialized knowledge, but many healthcare systems report a shortage of qualified nurses. This workforce shortage limits the scalability and consistency of care, reduces opportunities for patient education, and increases burnout of existing staff [153,154].
Healthcare fragmentation further hinders effective implementation. When communication between multidisciplinary team members is poor or disorganized, patients may experience gaps in continuity of care, conflicting advice, or duplicate services. Educational gaps among healthcare providers also contribute to inconsistent application of evidence-based care strategies, particularly in community or generalist settings [155,156].
Fear of treatment side effects and low health literacy among patients also affect adherence to healthcare-led interventions. Individuals often discontinue treatment due to concerns about long-term consequences such as weight gain, infections or gastrointestinal complications. In the absence of sustained counseling and trusting relationships with qualified nurses, many of these concerns remain unsolved, leading to premature withdrawal from treatment [157,158].
Technological and digital innovations, such as mobile health monitoring, virtual consultations, and patient empowerment apps, offer promising ways to address access and adherence challenges. However, barriers related to digital literacy, internet connectivity and system integration persist. Although telemedicine has improved continuity of care during crises such as the COVID-19 pandemic, its uptake remains uneven and cannot fully replace in-person assessment in many cases [159,160,161].
Another neglected barrier is the mental and emotional burden on both patients and their families. Chronic pain, fatigue, and disability can contribute to depression, anxiety, and social withdrawal, which in turn affect motivation and commitment to treatment plans. The lack of accessible psychological support integrated into rheumatologic care leaves a critical gap in service delivery [162,163].
Finally, institutional inertia, policy limitations, and underinvestment in medical education and care infrastructure inhibit systemic change. Without coordinated strategies to expand training programs, fund nurse-led clinics, and streamline multidisciplinary pathways, the broader impact of healthcare interventions on population health outcomes remains limited [164,165].

4. Discussion

The results of this synthesis highlight the central role that healthcare interventions play in the overall management of rheumatic diseases. Their impact is multifaceted, addressing physical, psychological, and social dimensions of health. However, the evidence reviewed also reveals critical complexities and contextual nuances that need to be addressed to optimize their implementation.
Non-pharmacological approaches such as joint protection, pain management through heat therapy, exercise, and patient education consistently demonstrate benefits in terms of symptom control and quality of life. However, variability in individual response and accessibility to these interventions remains substantial. Socioeconomic and geographic disparities continue to influence patients’ ability to engage in regular care, particularly in resource-limited settings where specialized care is insufficient or underfunded [166].
Patient adherence and activation levels differ significantly between disease types and care models. Individuals with chronic inflammatory arthritis often face unique psychological burdens, including isolation and reduced self-efficacy, which are exacerbated when multidisciplinary support is inconsistent or absent [167]. In addition, patients with osteoarthritis and other degenerative conditions may face a more fragmented trajectory of care, leading to increased emergency department visits that could otherwise be prevented by better outpatient support structures [168,169].
The relationship between systemic inflammation, comorbidities, and cardiovascular risks in patients with rheumatic diseases adds further complexity to the responsibilities of the nurse. Nurses are increasingly required to monitor cardiovascular health parameters and guide patients through lifestyle modification to mitigate long-term risks, often without the support of integrated cardiologic pathways [170].
Behavioral and motivational barriers are also evident. Even when nurse education is available, not all patients show adequate activation or compliance. This is particularly evident in younger patients or those with low health literacy, where passive roles in care persist despite efforts to promote self-management [171]. In addition, both patients and physicians may have conflicting expectations about the scope and effectiveness of chronic pain management, leading to dissonance in treatment goals and reduced therapeutic alliance [172].
Dietary interventions are emerging as promising adjunctive strategies, particularly anti-inflammatory diets, but current evidence remains inconsistent in terms of comparative effectiveness. More robust clinical trials are needed to establish superiority or synergism between different nutritional models and their interaction with pharmacologic regimens [173].
Digital health tools, including telemonitoring and remote coaching platforms, have demonstrated the potential to extend healthcare beyond clinical settings. However, issues of digital divide, lack of personalization, and inconsistent patient engagement remain barriers to their wider adoption [174].
Finally, the influence of socio-economic status on quality of life and medication adherence cannot be underestimated. Financial hardship, limited insurance coverage, and competing life demands often correlate with lower adherence and poorer health outcomes, underscoring the need for more equitable patterns of care and the integration of social support into health care plans [175].
In 2025, Juan Nicolás Cuenca-Zaldívar and his team established that the integration of climatic factors in the assessment and management of chronic musculoskeletal pain offers considerable opportunities for the development of personalized self-care strategies and thus contributes significantly to improving the quality of life of patients with rheumatic conditions [176].
In the light of these findings, it becomes clear that while healthcare interventions are essential, their success depends on a web of systemic, interpersonal and contextual factors. Future research and health policies need to address the heterogeneity of patient populations, strengthen multidisciplinary coordination, and prioritize accessibility to ensure that the benefits of specialized health care are universally realized.
This narrative analysis has several limitations that must be acknowledged when interpreting the findings. One of the main constraints is the exclusion of the gray literature, which could have led to the omission of relevant but unindexed data, such as conference proceedings, theses or institutional reports. Although rigorous inclusion criteria were applied, this may have introduced a publication bias, favoring studies with positive or statistically significant results.
Language restrictions are also a potential limitation, as only articles published in English were included in the review. This may have excluded valuable studies conducted in other languages, particularly from non-English speaking regions where the management of rheumatic diseases may differ due to cultural, infrastructural, or economic factors.
In addition, some of the studies lacked detailed reporting of care-specific outcomes, limiting the ability to assess the direct impact of care interventions on clinical parameters. In some cases, multidisciplinary interventions were reported without clearly distinguishing the contribution of the nursing component, complicating the attribution of outcomes.
Another limitation concerns the reliance on self-reported measures in many studies, particularly those assessing adherence to treatment, quality of life, or symptom severity. These measures are subject to reporting bias and may not accurately reflect objective clinical changes.
Finally, although this review included a broad time period and a large number of sources, it is possible that relevant studies published outside the selected period were excluded.

5. Conclusions

This review emphasizes the essential role of healthcare interventions in improving clinical outcomes and quality of life among patients with rheumatic diseases. In a variety of care settings, evidence suggests that tailored nursing strategies, both pharmacologic and non-pharmacologic, contribute significantly to pain relief, improved mobility, greater functional independence, and better adherence to treatment. The data highlight not only the effectiveness of individual interventions such as exercise programs, joint protection techniques, and patient education, but also the synergistic value of integrating them into long-term care plans.
The analysis shows that healthcare interventions are more effective when they are tailored to the specific type of disease and patient characteristics. Interventions for rheumatoid arthritis focus mainly on inflammation control and joint protection, while interventions for osteoarthritis target weight management and lifestyle modification. Patients with systemic lupus erythematosus benefit from multidisciplinary monitoring due to multi-organ involvement, further reinforcing the need for disease-specific care pathways.
Multidisciplinary collaboration has emerged as a central pillar of effective care. Nurses, when integrated into coordinated care teams alongside rheumatologists, physiotherapists, occupational therapists, psychologists and dieticians, are better positioned to provide holistic, patient-centered care. This interprofessional model not only improves clinical outcomes but also strengthens patient engagement, psychological well-being and continuity of care.
Despite these benefits, implementation of healthcare interventions faces persistent barriers. The review identifies systemic problems such as shortages of health workers, inequalities in access to specialized care and infrastructural disparities—particularly in rural or low-resource settings. Patient-related challenges, including low health literacy, fear of medication side effects and inconsistent adherence, further complicate care delivery.
Emerging solutions, such as the integration of digital health technologies, telemonitoring, and mobile health apps, offer promising avenues to extend the reach and responsiveness of healthcare interventions. However, their successful implementation requires careful design, user-friendly platforms, and support structures to overcome digital exclusion.
In general, the complexity of rheumatic disease care requires a multidimensional approach in which healthcare plays a strategic, adaptive, and evidence-based role. While existing research supports the efficacy of many nursing strategies, variability in study design, quality of evidence, and outcome measures highlights the need for more robust clinical trials, improved categorization of evidence, and standardization of reporting. Addressing these gaps will be essential for shaping future rheumatology nursing practice and ensuring equitable, high-quality care for all patients.

Author Contributions

Conceptualization, G.I.V.; Methodology, G.I.V.; Software, G.I.V.; Validation G.I.V., V.-C.Ș., M.N.M. and G.G.; Formal Analysis, G.I.V.; Investigation, G.I.V, C.L.P. and M.Ș.; Resources, G.I.V.; Data Curation, G.I.V. and D.-A.C.; Writing—Original Draft Preparation, G.I.V.; Writing—Review and Editing, G.I.V., D.-A.C. and D.C.V.; Visualization, G.I.V., A.A.Ș.B., D.-A.C., C.L.P., M.Ș., M.N.M., G.G., V.-C.Ș. and D.C.V.; Supervision, D.C.V.; Project Administration, G.I.V., and D.C.V. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Acknowledgments

The authors have reviewed and edited the output and take full responsibility for the content of this publication.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
ACPAanti-citrullinated protein antibodies
APSantiphospholipid syndrome
ASatherosclerosis
DMARDdisease-modifying antirheumatic drugs
bDMARDsbiologic disease-modifying antirheumatic drugs
CADcoronary artery disease
CRPC-reactive protein
CVDcardiovascular disease
DMdiabetes mellitus
EBVEpstein-Barr virus
EULAREuropean Alliance of Associations for Rheumatology
FLSfibroblast-like synoviocytes
HDLhigh-density lipoprotein
ICAM-1intercellular adhesion molecule-1
IL-1interleukin-1
IL-1βinterleukin-1 beta
IL-6interleukin-6
LDLlow-density lipoprotein
MMPsmatrix metalloproteinases
MRImagnetic resonance imaging
NF-κBkappa-light-chain-enhancer of activated B cells
NSAIDsnonsteroidal anti-inflammatory drugs
OAosteoarthritis
RArheumatoid arthritis
RFrheumatoid factor
SLEsystemic lupus erythematosus
TENStranscutaneous electrical nerve stimulation
TNF-αfactor-alpha
VCAM-1vascular cell adhesion molecule-1
WHOWorld Health Organization

References

  1. Koo, M.; Lu, M.-C. Rheumatic Diseases: New Progress in Clinical Research and Pathogenesis. Medicina 2023, 59, 1581. [Google Scholar] [CrossRef]
  2. Wu, D.; Luo, Y.; Li, T.; Zhao, X.; Lv, T.; Fang, G.; Ou, P.; Li, H.; Luo, X.; Huang, A.; et al. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front. Immunol. 2022, 13, 1051082. [Google Scholar] [CrossRef] [PubMed]
  3. Mueller, A.-L.; Payandeh, Z.; Mohammadkhani, N.; Mubarak, S.M.H.; Zakeri, A.; Bahrami, A.A.; Brockmueller, A.; Shakibaei, M. Recent Advances in Understanding the Pathogenesis of Rheumatoid Arthritis: New Treatment Strategies. Cells 2021, 10, 3017. [Google Scholar] [CrossRef]
  4. Jang, D.-I.; Lee, A.-H.; Shin, H.-Y.; Song, H.-R.; Park, J.-H.; Kang, T.-B.; Lee, S.-R.; Yang, S.-H. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. Int. J. Mol. Sci. 2021, 22, 2719. [Google Scholar] [CrossRef]
  5. Ramos-Casals, M.; Brito-Zerón, P.; Bombardieri, S.; Bootsma, H.; De Vita, S.; Dörner, T.; Fisher, B.A.; Gottenberg, J.E.; Hernandez-Molina, G.; Kocher, A.; et al. EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies. Ann. Rheum. Dis. 2020, 79, 3–18. [Google Scholar] [CrossRef] [PubMed]
  6. Schäfer, C.; Keyßer, G. Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A Narrative Review. J. Clin. Med. 2022, 11, 7179. [Google Scholar] [CrossRef] [PubMed]
  7. Mills, G.A.; Dey, D.; Kassim, M.; Yiwere, A.; Broni, K. Diagnostic Tool for Early Detection of Rheumatic Disorders Using Machine Learning Algorithm and Predictive Models. BioMedInformatics 2024, 4, 1174–1201. [Google Scholar] [CrossRef]
  8. Inchingolo, F.; Inchingolo, A.M.; Fatone, M.C.; Avantario, P.; Del Vecchio, G.; Pezzolla, C.; Mancini, A.; Galante, F.; Palermo, A.; Inchingolo, A.D.; et al. Management of Rheumatoid Arthritis in Primary Care: A Scoping Review. Int. J. Environ. Res. Public Health 2024, 21, 662. [Google Scholar] [CrossRef]
  9. Hill, A.P.; Iqbal, S.B.; Case, B.C.; Shankar, A.A.; Merdler, I. Acute Coronary Syndrome and Rheumatic Disease. J. Clin. Med. 2025, 14, 1490. [Google Scholar] [CrossRef]
  10. World Health Organization (WHO). Musculoskeletal Health; World Health Organization: Geneva, Switzerland, 2022.
  11. Nikiphorou, E.; Santos, E.J.F.; Marques, A.; Böhm, P.; Bijlsma, J.W.; Daien, C.I.; Esbensen, B.A.; Ferreira, R.J.; Fragoulis, G.E.; Holmes, P.; et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann. Rheum. Dis. 2021, 80, 1278–1285. [Google Scholar] [CrossRef]
  12. Shumnalieva, R.; Kotov, G.; Monov, S. Obesity-Related Knee Osteoarthritis—Current Concepts. Life 2023, 13, 1650. [Google Scholar] [CrossRef] [PubMed]
  13. Ishikawa, Y.; Terao, C. The Impact of Cigarette Smoking on Risk of Rheumatoid Arthritis: A Narrative Review. Cells 2020, 9, 475. [Google Scholar] [CrossRef] [PubMed]
  14. Devirgiliis, C.; Guberti, E.; Mistura, L.; Raffo, A. Effect of Fruit and Vegetable Consumption on Human Health: An Update of the Literature. Foods 2024, 13, 3149. [Google Scholar] [CrossRef]
  15. Shuvo, S.D.; Hossen, M.T.; Riazuddin, M.; Hossain, M.S.; Mazumdar, S.; Parvin, R.; Elahi, M.T. Prevalence of Comorbidities and Its Associated Factors among Type-2 Diabetes Patients: A Hospital-Based Study in Jashore District, Bangladesh. BMJ Open 2023, 13, e076261. [Google Scholar] [CrossRef] [PubMed]
  16. Sundaresan, B.; Shirafkan, F.; Ripperger, K.; Rattay, K. The Role of Viral Infections in the Onset of Autoimmune Diseases. Viruses 2023, 15, 782. [Google Scholar] [CrossRef]
  17. Rigante, D.; Esposito, S. Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? Int. J. Mol. Sci. 2015, 16, 17331–17343. [Google Scholar] [CrossRef]
  18. Moysidou, E.; Christodoulou, M.; Lioulios, G.; Stai, S.; Karamitsos, T.; Dimitroulas, T.; Fylaktou, A.; Stangou, M. Lymphocytes Change Their Phenotype and Function in Systemic Lupus Erythematosus and Lupus Nephritis. Int. J. Mol. Sci. 2024, 25, 10905. [Google Scholar] [CrossRef]
  19. Aletaha, D. Precision medicine and management of rheumatoid arthritis. J. Autoimmun. 2020, 110, 102405. [Google Scholar] [CrossRef] [PubMed]
  20. Laurindo, L.F.; de Maio, M.C.; Barbalho, S.M.; Guiguer, E.L.; Araújo, A.C.; de Alvares Goulart, R.; Flato, U.A.P.; Júnior, E.B.; Detregiachi, C.R.P.; dos Santos Haber, J.F.; et al. Organokines in Rheumatoid Arthritis: A Critical Review. Int. J. Mol. Sci. 2022, 23, 6193. [Google Scholar] [CrossRef]
  21. Infante, B.; Mercuri, S.; Strologo, A.D.; Franzin, R.; Catalano, V.; Troise, D.; Cataldo, E.; Pontrelli, P.; Alfieri, C.; Binda, V.; et al. Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies. Int. J. Mol. Sci. 2022, 23, 15998. [Google Scholar] [CrossRef]
  22. Medina-Leyte, D.J.; Zepeda-García, O.; Domínguez-Pérez, M.; González-Garrido, A.; Villarreal-Molina, T.; Jacobo-Albavera, L. Endothelial Dysfunction, Inflammation and Coronary Artery Disease: Potential Biomarkers and Promising Therapeutical Approaches. Int. J. Mol. Sci. 2021, 22, 3850. [Google Scholar] [CrossRef]
  23. Ermencheva, P.; Kotov, G.; Shumnalieva, R.; Velikova, T.; Monov, S. Exploring the Role of the Microbiome in Rheumatoid Arthritis—A Critical Review. Microorganisms 2024, 12, 1387. [Google Scholar] [CrossRef]
  24. Blachut, D.; Mazurkiewicz, M.; Schulz, M.; Cieśla, J.; Przywara-Chowaniec, B.; Tomasik, A. Update: Heart Failure in Systemic Lupus Erythematosus. Appl. Sci. 2025, 15, 1590. [Google Scholar] [CrossRef]
  25. Godbole, S.; Solomon, J.L.; Johnson, M.; Srivastava, A.; Carsons, S.E.; Belilos, E.; De Leon, J.; Reiss, A.B. Treating Cardiovascular Disease in the Inflammatory Setting of Rheumatoid Arthritis: An Ongoing Challenge. Biomedicines 2024, 12, 1608. [Google Scholar] [CrossRef] [PubMed]
  26. Chang, C.-K.; Chiang, E.-P.I.; Chang, K.-H.; Tang, K.-T.; Chen, P.-K.; Yip, H.-T.; Chen, C.-H.; Chen, D.-Y. The Sizes and Composition of HDL-Cholesterol Are Significantly Associated with Inflammation in Rheumatoid Arthritis Patients. Int. J. Mol. Sci. 2023, 24, 10645. [Google Scholar] [CrossRef] [PubMed]
  27. Rafaqat, S.; Gluscevic, S.; Mercantepe, F.; Rafaqat, S.; Klisic, A. Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease. Metabolites 2024, 14, 153. [Google Scholar] [CrossRef]
  28. Cacciapaglia, F.; Spinelli, F.R.; Bartoloni, E.; Bugatti, S.; Erre, G.L.; Fornaro, M.; Manfredi, A.; Piga, M.; Sakellariou, G.; Viapiana, O.; et al. Clinical Features of Diabetes Mellitus on Rheumatoid Arthritis: Data from the Cardiovascular Obesity and Rheumatic DISease (CORDIS) Study Group. J. Clin. Med. 2023, 12, 2148. [Google Scholar] [CrossRef]
  29. Jakubowski, H.; Witucki, Ł. Homocysteine Metabolites, Endothelial Dysfunction, and Cardiovascular Disease. Int. J. Mol. Sci. 2025, 26, 746. [Google Scholar] [CrossRef]
  30. Athanassiou, L.; Kostoglou-Athanassiou, I.; Koutsilieris, M.; Shoenfeld, Y. Vitamin D and Autoimmune Rheumatic Diseases. Biomolecules 2023, 13, 709. [Google Scholar] [CrossRef]
  31. Bajic, Z.; Sobot, T.; Skrbic, R.; Stojiljkovic, M.P.; Ponorac, N.; Matavulj, A.; Djuric, D.M. Homocysteine, Vitamins B6 and Folic Acid in Experimental Models of Myocardial Infarction and Heart Failure—How Strong Is That Link? Biomolecules 2022, 12, 536. [Google Scholar] [CrossRef]
  32. Hong, H.; Chen, L.; Zhong, Y.; Yang, Z.; Li, W.; Song, C.; Leng, H. Associations of Homocysteine, Folate, and Vitamin B12 with Osteoarthritis: A Mendelian Randomization Study. Nutrients 2023, 15, 1636. [Google Scholar] [CrossRef] [PubMed]
  33. Richter, P.; Macovei, L.A.; Mihai, I.R.; Cardoneanu, A.; Burlui, M.A.; Rezus, E. Cytokines in Systemic Lupus Erythematosus—Focus on TNF-α and IL-17. Int. J. Mol. Sci. 2023, 24, 14413. [Google Scholar] [CrossRef]
  34. Poznyak, A.V.; Kirichenko, T.V.; Beloyartsev, D.F.; Churov, A.V.; Kovyanova, T.I.; Starodubtseva, I.A.; Sukhorukov, V.N.; Antonov, S.A.; Orekhov, A.N. Rheumatoid Arthritis: What Inflammation Do We Face? J. Mol. Pathol. 2024, 5, 454–465. [Google Scholar] [CrossRef]
  35. González Heredia, T.; Hernández Corona, D.M.; Méndez del Villar, M.; Guzmán Ornelas, M.O.; Corona Meraz, F.I.; Chávez Tostado, M.; Diosdado Pardo, G.E.; Pérez Padilla, A.J.; Pérez Villalobos, F.B.; Montaño Vargas, P.Y.; et al. Adjunctive Therapies in Rheumatoid Arthritis. Nutraceuticals 2024, 4, 643–657. [Google Scholar] [CrossRef]
  36. Katkenov, N.; Mukhatayev, Z.; Kozhakhmetov, S.; Sailybayeva, A.; Bekbossynova, M.; Kushugulova, A. Systematic Review on the Role of IL-6 and IL-1β in Cardiovascular Diseases. J. Cardiovasc. Dev. Dis. 2024, 11, 206. [Google Scholar] [CrossRef] [PubMed]
  37. Pandolfi, F.; Franza, L.; Carusi, V.; Altamura, S.; Andriollo, G.; Nucera, E. Interleukin-6 in Rheumatoid Arthritis. Int. J. Mol. Sci. 2020, 21, 5238. [Google Scholar] [CrossRef]
  38. Santosa, A.; Li, J.W.; Tan, T.C. Digital Health for Equitable Rheumatic Care: Integrating Real-World Experiences to Guide Policy Pathways. Healthcare 2025, 13, 438. [Google Scholar] [CrossRef] [PubMed]
  39. Jang, S.; Kwon, E.-J.; Lee, J.J. Rheumatoid Arthritis: Pathogenic Roles of Diverse Immune Cells. Int. J. Mol. Sci. 2022, 23, 905. [Google Scholar] [CrossRef]
  40. Pietschmann, P.; Butylina, M.; Kerschan-Schindl, K.; Sipos, W. Mechanisms of Systemic Osteoporosis in Rheumatoid Arthritis. Int. J. Mol. Sci. 2022, 23, 8740. [Google Scholar] [CrossRef]
  41. Rezuș, E.; Macovei, L.A.; Burlui, A.M.; Cardoneanu, A.; Rezuș, C. Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background. Life 2021, 11, 1042. [Google Scholar] [CrossRef]
  42. Sircana, M.C.; Erre, G.L.; Castagna, F.; Manetti, R. Crosstalk between Inflammation and Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus: Is There a Common Basis? Life 2024, 14, 716. [Google Scholar] [CrossRef]
  43. Narazaki, M.; Kishimoto, T. The Two-Faced Cytokine IL-6 in Host Defense and Diseases. Int. J. Mol. Sci. 2018, 19, 3528. [Google Scholar] [CrossRef] [PubMed]
  44. Maeda, K.; Yoshida, K.; Nishizawa, T.; Otani, K.; Yamashita, Y.; Okabe, H.; Hadano, Y.; Kayama, T.; Kurosaka, D.; Saito, M. Inflammation and Bone Metabolism in Rheumatoid Arthritis: Molecular Mechanisms of Joint Destruction and Pharmacological Treatments. Int. J. Mol. Sci. 2022, 23, 2871. [Google Scholar] [CrossRef] [PubMed]
  45. Gerasimova, E.V.; Popkova, T.V.; Kirillova, I.G.; Gerasimova, D.A.; Nasonov, E.L.; Lila, A.M. Interleukin-6: Cardiovascular Aspects of Long-Term Cytokine Suppression in Patients with Rheumatoid Arthritis. Int. J. Mol. Sci. 2024, 25, 12425. [Google Scholar] [CrossRef] [PubMed]
  46. Miyamoto, T. Osteoporosis and Rheumatoid Arthritis: Mechanisms Underlying Osteoclast Differentiation and Activation or Factors Associated with Hip Fractures. J. Clin. Med. 2025, 14, 1138. [Google Scholar] [CrossRef]
  47. Smolinska, V.; Klimova, D.; Danisovic, L.; Harsanyi, S. Synovial Fluid Markers and Extracellular Vesicles in Rheumatoid Arthritis. Medicina 2024, 60, 1945. [Google Scholar] [CrossRef]
  48. Orsini, F.; Crotti, C.; Cincinelli, G.; Di Taranto, R.; Amati, A.; Ferrito, M.; Varenna, M.; Caporali, R. Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review. Biology 2023, 12, 1320. [Google Scholar] [CrossRef]
  49. Liu, Y.; Wang, Y.; Yan, P.; Cui, N.; Xu, K.; Liu, D.; Tian, Y.; Cao, L. NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics. Biology 2025, 14, 71. [Google Scholar] [CrossRef]
  50. Restivo, V.; Candiloro, S.; Daidone, M.; Norrito, R.; Cataldi, M.; Minutolo, G.; Caracci, F.; Fasano, S.; Ciccia, F.; Casuccio, A.; et al. Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus. Autoimmun. Rev. 2022, 21, 102925. [Google Scholar] [CrossRef]
  51. Bakinowska, E.; Kiełbowski, K.; Pawlik, A. The Role of Extracellular Vesicles in the Pathogenesis and Treatment of Rheumatoid Arthritis and Osteoarthritis. Cells 2023, 12, 2716. [Google Scholar] [CrossRef]
  52. Foers, A.D.; Garnham, A.L.; Chatfield, S.; Smyth, G.K.; Cheng, L.; Hill, A.F.; Wicks, I.P.; Pang, K.C. Extracellular Vesicles in Synovial Fluid from Rheumatoid Arthritis Patients Contain miRNAs with Capacity to Modulate Inflammation. Int. J. Mol. Sci. 2021, 22, 4910. [Google Scholar] [CrossRef] [PubMed]
  53. Opałka, B.; Żołnierczuk, M.; Grabowska, M. Immunosuppressive Agents—Effects on the Cardiovascular System and Selected Metabolic Aspects: A Review. J. Clin. Med. 2023, 12, 6935. [Google Scholar] [CrossRef] [PubMed]
  54. Bedeković, D.; Bošnjak, I.; Šarić, S.; Kirner, D.; Novak, S. Role of Inflammatory Cytokines in Rheumatoid Arthritis and Development of Atherosclerosis: A Review. Medicina 2023, 59, 1550. [Google Scholar] [CrossRef] [PubMed]
  55. Dijkshoorn, B.; Raadsen, R.; Nurmohamed, M.T. Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022. J. Clin. Med. 2022, 11, 2704. [Google Scholar] [CrossRef]
  56. Peleg, H.; Ben-Chetrit, E. Impact of Endocrine Disorders on Autoimmune Diseases. In Endocrinology and Systemic Diseases; Portincasa, P., Frühbeck, G., Nathoe, H.M., Eds.; Springer: Cham, Switzerland, 2021. [Google Scholar]
  57. Athanassiou, L.; Kostoglou-Athanassiou, I.; Kaiafa, G.; Tsakiridis, P.; Koukosias, N.; Mitsoulis, S.; Savopoulos, C.; Athanassiou, P. Thyroid Disease and Systemic Lupus Erythematosus. Medicina 2023, 59, 1911. [Google Scholar] [CrossRef]
  58. López-Pedrera, C.; Barbarroja, N.; Jimenez-Gomez, Y.; Collantes-Estevez, E.; Aguirre, M.A.; Cuadrado, M.J. Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: New therapeutic approaches. Rheumatology 2016, 55, 2096–2108. [Google Scholar] [CrossRef]
  59. Wu, C.-Y.; Yang, H.-Y.; Lai, J.-H. Anti-Citrullinated Protein Antibodies in Patients with Rheumatoid Arthritis: Biological Effects and Mechanisms of Immunopathogenesis. Int. J. Mol. Sci. 2020, 21, 4015. [Google Scholar] [CrossRef]
  60. Stark, K.; Massberg, S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat. Rev. Cardiol. 2021, 18, 666–682. [Google Scholar] [CrossRef]
  61. Gerasimova, E.V.; Popkova, T.V.; Gerasimova, D.A.; Markina, Y.V.; Kirichenko, T.V. Subclinical Carotid Atherosclerosis in Patients with Rheumatoid Arthritis at Low Cardiovascular Risk. Biomedicines 2023, 11, 974. [Google Scholar] [CrossRef]
  62. Korman, N.J. Management of psoriasis as a systemic disease: What is the evidence? Br. J. Dermatol. 2020, 182, 840–848. [Google Scholar] [CrossRef]
  63. Hedar, A.M.; Stradner, M.H.; Roessler, A.; Goswami, N. Autoimmune Rheumatic Diseases and Vascular Function: The Concept of Autoimmune Atherosclerosis. J. Clin. Med. 2021, 10, 4427. [Google Scholar] [CrossRef] [PubMed]
  64. Olímpio, J.A.; Araújo, J.N.M.; Pitombeira, D.O.; Enders, B.C.; Sonenberg, A.; Vitor, A.F. Advanced practice nursing: A concept analysis. Acta Paul. De Enferm. 2018, 31, 674–678. [Google Scholar] [CrossRef]
  65. British Society for Rheumatology. Specialist Nursing in Rheumatology. The State of Play. Available online: https://www.rheumatology.org.uk/Portals/0/Documents/Policy/Reports/Specialist_nursing_rheumatology_2019_State_of_Play.pdf?ver=2019-04-24-170948-180 (accessed on 1 May 2025).
  66. Maghsoud, F.; Rezaei, M.; Asgarian, F.S.; Rassouli, M. Workload and quality of nursing care: The mediating role of implicit rationing of nursing care, job satisfaction and emotional exhaustion by using structural equations modeling approach. BMC Nurs. 2022, 21, 273. [Google Scholar] [CrossRef]
  67. Riley, L.; Harris, C.; McKay, M.; Gondran, S.E.; DeCola, P.; Soonasra, A. The role of nurses in the delivery of rheumatology care and services: Results of a US survey. J. Am. Assoc. Nurse Pract. 2017, 29, 673–681. [Google Scholar] [CrossRef] [PubMed]
  68. Rohan, T.Z.; Hafer, R.; Duong, T.; Dasgupta, R.; Yang, S. Hidradenitis Suppurativa Is Associated with an Increased Risk of Adverse Cardiac Events and All-Cause Mortality. J. Clin. Med. 2025, 14, 1110. [Google Scholar] [CrossRef]
  69. Gillespie, H. Spondyloarthritis. In Interdisciplinary Rheumatology; CRC Press: Boca Raton, FL, USA, 2024; pp. 37–47. [Google Scholar]
  70. Kattamuri, L.; Duggal, S.; Aparece, J.P.; Sairam, S. Cardiovascular Risk Factor and Atherosclerosis in Rheumatoid Arthritis (RA). Curr. Cardiol. Rep. 2025, 27, 31. [Google Scholar] [CrossRef]
  71. Zinglersen, L.; Zinglersen, A.H.; Myhr, K.A.; Hermansen, M.-L.; Kofoed, K.F.; Fuchs, A.; Diederichsen, L.P.; Jacobsen, S. Coronary artery calcification progression and renal involvement in patients with systemic lupus erythematosus: A longitudinal cohort study. Rheumatol. Int. 2025, 45, 26. [Google Scholar] [CrossRef]
  72. Saviano, A.; Loprete, M.R.M.; Pignataro, G.; Piccioni, A.; Gasbarrini, A.; Franceschi, F.; Candelli, M. Helicobacter pylori, Atherosclerosis, and Coronary Artery Disease: A Narrative Review. Medicina 2025, 61, 346. [Google Scholar] [CrossRef]
  73. Karpouzas, G.A.; Bui, V.L.; Ronda, N.; Hollan, I.; Ormseth, S.R. Biologics and atherosclerotic cardiovascular risk in rheumatoid arthritis: A review of evidence and mechanistic insights. Expert Rev. Clin. Immunol. 2021, 17, 355–374. [Google Scholar] [CrossRef]
  74. Semb, A.G.; Ikdahl, E.; Wibetoe, G.; Crowson, C.; Rollefstad, S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat. Rev. Rheumatol. 2020, 16, 361–379. [Google Scholar] [CrossRef]
  75. Fedorchenko, Y.; Yessirkepov, M.; Doskaliuk, B.; Zaiats, L.; Mahmudov, K. Thyroid disease as a comorbidity in inflammatory rheumatic diseases. Rheumatol. Int. 2025, 45, 46. [Google Scholar] [CrossRef] [PubMed]
  76. Sivalingam, A.M. Emerging Mechanisms and Biomarkers Associated with T-Cells and B-Cells in Autoimmune Disorders. Clin. Rev. Allergy Immunol. 2025, 68, 14. [Google Scholar] [CrossRef] [PubMed]
  77. Page, M.J.; McKenzie, J.E.; Bossuyt, P.M.; Boutron, I.; Hoffmann, T.C.; Mulrow, C.D.; Shamseer, L.; Tetzlaff, J.M.; Akl, E.A.; Brennan, S.E.; et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ 2021, 372, 71. [Google Scholar] [CrossRef]
  78. Shamseer, L.; Moher, D.; Clarke, M.; Ghersi, D.; Liberati, A.; Petticrew, M.; Shekelle, P.; Stewart, L.A. The PRISMA-P Group Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ 2015, 349, g7647. [Google Scholar] [CrossRef] [PubMed]
  79. Du, J.; Bai, Y.; Yu, Y. Research on the Application of Continuous Nursing Model in Postoperative Rehabilitation of Patients with Lower Extremity Varicose Veins. Eval. Health Prof. 2025. [Google Scholar] [CrossRef]
  80. Imdad, U.; Tariq, F.; Molnar, P.; Forgach, J.S.; Salama, H.; Ansari, Y.Z.; Halalmeh, D.R. Pain Management and Rehabilitation. In Osteomyelitis and Discitis of the Spine; Academic Press: Cambridge, MA, USA, 2025; pp. 429–442. [Google Scholar]
  81. Wang, Y.; Aaron, R.; Attal, N.; Colloca, L. An update on non-pharmacological interventions for pain relief. Cell Rep. Med. 2025, 6, 101940. [Google Scholar] [CrossRef]
  82. Rehman, S.U.; Chopra, V.S.; Dar, M.A.; Maqbool, M.; Qadrie, Z.; Qadir, A. Advancing rheumatic disease treatment: A journey towards better lives. Open Health 2024, 5, 20230040. [Google Scholar] [CrossRef]
  83. Sturgeon, J.A.; Finan, P.H.; Zautra, A.J. Affective disturbance in rheumatoid arthritis: Psychological and disease-related pathways. Nat. Rev. Rheumatol. 2016, 12, 532–542. [Google Scholar] [CrossRef]
  84. Dixit, T.; Vaidya, A.; Ravindran, S. Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Futur. Sci. OA 2025, 11, 2467591. [Google Scholar] [CrossRef]
  85. Francese, R.; Rittà, M.; Lembo, D.; Donalisio, M. Lupus and SARS-CoV-2: What Have We Learned after the Pandemic? Lupus 2025, 34, 117–132. [Google Scholar] [CrossRef]
  86. Minnock, P.; McKee, G.; Kelly, A.; Carter, S.C.; Menzies, V.; O’sUllivan, D.; Richards, P.; Ndosi, M.; Hustings, Y.v.E. Nursing sensitive outcomes in patients with rheumatoid arthritis: A systematic literature review. Int. J. Nurs. Stud. 2018, 77, 115–129. [Google Scholar] [CrossRef] [PubMed]
  87. Dougados, M.; Soubrier, M.; Perrodeau, E.; Gossec, L.; Fayet, F.; Gilson, M.; Cerato, M.-H.; Pouplin, S.; Flipo, R.-M.; Chabrefy, L.; et al. Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: Results of a prospective, multicentre, randomised, controlled trial (COMEDRA). Ann. Rheum. Dis. 2015, 74, 1725–1733. [Google Scholar] [CrossRef]
  88. Mucke, J.; Simon, H.U.; Burmester, G.R. The Safety of Antirheumatic Drugs. Dtsch. Ärztebl. Int. 2022, 119, 81. [Google Scholar] [CrossRef]
  89. Ledingham, J.; Snowden, N.; Ide, Z. Diagnosis and early management of inflammatory arthritis. BMJ 2017, 358, j3248. [Google Scholar] [CrossRef]
  90. Küçükdeveci, A.A. Nonpharmacological treatment in established rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2019, 33, 101482. [Google Scholar] [CrossRef] [PubMed]
  91. Martin, A.; Chopra, R.; Nicassio, P.M. Nonpharmacologic Pain Management in Inflammatory Arthritis. Rheum. Dis. Clin. 2021, 47, 277–295. [Google Scholar] [CrossRef]
  92. Carsons, S.E.; Vivino, F.B.; Parke, A.; Carteron, N.; Sankar, V.; Brasington, R.; Mandel, S. Treatment Guidelines for Rheumatologic Manifestations of Sjögren’s Syndrome: Use of Biologic Agents, Management of Fatigue, and Inflammatory Musculoskeletal Pain. Arthritis Care Res. 2017, 69, 517–527. [Google Scholar] [CrossRef] [PubMed]
  93. Leochico, C.F.D.; Rey-Matias, R.R. Nonpharmacologic Modalities for Chronic Pain. In Advances in Chronic and Neuropathic Pain; Springer: Berlin/Heidelberg, Germany, 2022; pp. 299–312. [Google Scholar]
  94. Straub, R.H.; Cutolo, M. A History of Psycho-Neuro-Endocrine Immune Interactions in Rheumatic Diseases. Neuroimmunomodulation 2024, 31, 183–210. [Google Scholar] [CrossRef]
  95. Musumeci, G. Effects of exercise on physical limitations and fatigue in rheumatic diseases. World J. Orthop. 2015, 6, 762–769. [Google Scholar] [CrossRef]
  96. Melis, M.R.; El Aoufy, K.; Bambi, S.; Bruni, C.; Guiducci, S.; Bellando-Randone, S.; Matucci-Cerinic, M.; Rasero, L. Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: A systematic literature review. Clin. Rheumatol. 2023, 42, 1521–1535. [Google Scholar] [CrossRef]
  97. Alnaqbi, K.A.; Hannawi, S.; Namas, R.; Alshehhi, W.; Badsha, H.; Al-Saleh, J. Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE. Int. J. Rheum. Dis. 2022, 25, 725–732. [Google Scholar] [CrossRef] [PubMed]
  98. Bierma-Zeinstra, S.; van Middelkoop, M.; Runhaar, J.; Schiphof, D. Nonpharmacological and nonsurgical approaches in OA. Best Pract. Res. Clin. Rheumatol. 2020, 34, 101564. [Google Scholar] [CrossRef] [PubMed]
  99. Shao, J.-H.; Yu, K.-H.; Chen, S.-H. Effectiveness of a self-management program for joint protection and physical activity in patients with rheumatoid arthritis: A randomized controlled trial. Int. J. Nurs. Stud. 2021, 116, 103752. [Google Scholar] [CrossRef] [PubMed]
  100. Poh, L.; He, H.G.; Lee, C.; Cheung, P.; Chan, W. An integrative review of experiences of patients with rheumatoid arthritis. Int. Nurs. Rev. 2015, 62, 231–247. [Google Scholar] [CrossRef] [PubMed]
  101. Gavin, J.P.; Rossiter, L.; Fenerty, V.; Leese, J.; Adams, J.; Hammond, A.; Davidson, E.; Backman, C.L. The Impact of Occupational Therapy on the Self-Management of Rheumatoid Arthritis: A Mixed Methods Systematic Review. ACR Open Rheumatol. 2024, 6, 214–249. [Google Scholar] [CrossRef]
  102. Fragoulis, G.E.; Edelaar, L.; Vliet Vlieland, T.P.M.; Iagnocco, A.; Schäfer, V.S.; Haines, C.; Schoones, J.; Nikiphorou, E. Development of generic core competences of health professionals in rheumatology: A systematic literature review informing the 2018 EULAR recommendations. RMD Open 2019, 5, e001028, Erratum in: RMD Open 2019, 5, e001028corr1. https://doi.org/10.1136/rmdopen-2019-001028corr1. [Google Scholar] [CrossRef] [PubMed Central]
  103. Fedorchenko, Y.; Mahmudov, K.; Abenov, Z.; Zimba, O.; Yessirkepov, M. Rehabilitation of patients with inflammatory rheumatic diseases and comorbidities: Unmet needs. Rheumatol. Int. 2024, 44, 583–591. [Google Scholar] [CrossRef]
  104. Valaas, H.L.; Klokkerud, M.; Hildeskår, J.; Hagland, A.S.; Kjønli, E.; Mjøsund, K.; Øie, L.; Wigers, S.H.; Eppeland, S.G.; Høystad, T.Ø.; et al. Follow-up care and adherence to self-management activities in rehabilitation for patients with rheumatic and musculoskeletal diseases: Results from a multicentre cohort study. Disabil. Rehabil. 2021, 44, 8001–8010. [Google Scholar] [CrossRef]
  105. Najm, A.; Gossec, L.; Weill, C.; Benoist, D.; Berenbaum, F.; Nikiphorou, E. Mobile Health Apps for Self-Management of Rheumatic and Musculoskeletal Diseases: Systematic Literature Review. JMIR mHealth uHealth 2019, 7, e14730. [Google Scholar] [CrossRef]
  106. Auyezkhankyzy, D.; Khojakulova, U.; Yessirkepov, M.; Qumar, A.B.; Zimba, O.; Kocyigit, B.F.; Akaltun, M.S. Nurses’ roles, interventions, and implications for management of rheumatic diseases. Rheumatol. Int. 2024, 44, 975–983. [Google Scholar] [CrossRef]
  107. Bednarek, A.; Klepacz, R.; Bodys-Cupak, I.E. The Role of the Nurse in the Care and Management of Patients with Rheumatic Diseases Arising from the Current EULAR Recommendations: A Literature Review. Healthcare 2023, 11, 2434. [Google Scholar] [CrossRef] [PubMed]
  108. Vadell, A.K.; Bärebring, L.; Hulander, E.; Gjertsson, I.; Lindqvist, H.M.; Winkvist, A. Anti-Inflammatory Diet in Rheumatoid Arthritis (ADIRA)—A Randomized, Controlled Crossover Trial Indicating Effects on Disease Activity. Am. J. Clin. Nutr. 2020, 111, 1203–1213. [Google Scholar] [CrossRef] [PubMed]
  109. Raad, T.; Griffin, A.; George, E.S.; Larkin, L.; Fraser, A.; Kennedy, N.; Tierney, A.C. Dietary Interventions with or without Omega-3 Supplementation for the Management of Rheumatoid Arthritis: A Systematic Review. Nutrients 2021, 13, 3506. [Google Scholar] [CrossRef] [PubMed]
  110. Primdahl, J.; Bremander, A.; Hendricks, O.; Østergaard, M.; Latocha, K.M.; Andersen, L.; Jensen, K.V.; Esbensen, B.A. Development of a complex Interdisciplinary Nurse-coordinated SELf-MAnagement (INSELMA) intervention for patients with inflammatory arthritis. BMC Health Serv. Res. 2024, 24, 87. [Google Scholar] [CrossRef]
  111. Bech, B.; Primdahl, J.; van Tubergen, A.; Voshaar, M.; Zangi, H.A.; Barbosa, L.; Boström, C.; Boteva, B.; Carubbi, F.; Fayet, F.; et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann. Rheum. Dis. 2020, 79, 61–68. [Google Scholar] [CrossRef]
  112. EULAR Points to Consider for the Prevention, Screening, Assessment and Management of Non-Adherence to Treatment in People with Rheumatic and Musculoskeletal Diseases for Use in Clinical Practice. Ann. Rheum. Dis. 2021, 80, 707–713. [CrossRef]
  113. Galoppini, G.; Marangoni, A.; Cirilli, F.; Ruffilli, F.; Garaffoni, C.; Govoni, M.; Scirè, C.A.; Silvagni, E.; Bortoluzzi, A. Optimizing Patient Care: A Systematic Review of Multidisciplinary Approaches for SLE Management. J. Clin. Med. 2023, 12, 4059. [Google Scholar] [CrossRef]
  114. Broderick, J.E.; Keefe, F.J.; Bruckenthal, P.; Junghaenel, D.U.; Schneider, S.; Schwartz, J.E.; Kaell, A.T.; Caldwell, D.S.; McKee, D.; Reed, S.; et al. Nurse practitioners can effectively deliver pain coping skills training to osteoarthritis patients with chronic pain: A randomized, controlled trial. PAIN® 2014, 155, 1743–1754. [Google Scholar] [CrossRef]
  115. Zangi, H.A.; Ndosi, M.; Adams, J.; Andersen, L.; Bode, C.; Boström, C.; Van Eijk-Hustings, Y.; Gossec, L.; Korandová, J.; Mendes, G.; et al. EULAR recommendations for patient education for people with inflammatory arthritis. Ann. Rheum. Dis. 2015, 74, 954–962. [Google Scholar] [CrossRef]
  116. van Middendorp, H.; Evers, A.W. The Role of Psychological Factors in Inflammatory Rheumatic Diseases: From Burden to Tailored Treatment. Best Pract. Res. Clin. Rheumatol. 2016, 30, 932–945. [Google Scholar] [CrossRef]
  117. Ploesser, M.; Silverman, S.; Diaz, J.D.L.; Zincke, M.T.; Taylor, M.B. The link between traumatic stress and autoimmune rheumatic diseases: A systematic scoping review. Semin. Arthritis Rheum. 2024, 69, 152558. [Google Scholar] [CrossRef] [PubMed]
  118. Branco, J.C.; Rodrigues, A.M.; Gouveia, N.; Eusébio, M.; Ramiro, S.; Machado, P.M.; da Costa, L.P.; Mourão, A.F.; Silva, I.; Laires, P.; et al. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: Results from EpiReumaPt– a national health survey. RMD Open 2016, 2, e000166. [Google Scholar] [CrossRef] [PubMed]
  119. Moe, R.H.; Vlieland, T.P.M.V. Current and Future Challenges for Rehabilitation for Inflammatory Arthritis. J. Clin. Med. 2024, 13, 1808. [Google Scholar] [CrossRef] [PubMed]
  120. Lempp, H.; Baggott, R.; Scott, D.L.; Parker, L.; Bosworth, A.; Georgopoulou, S.; Firth, J. The value, impact and role of nurses in rheumatology outpatient care: Critical review of the literature. Musculoskelet. Care 2020, 18, 245–255. [Google Scholar] [CrossRef]
  121. Fitzpatrick, J.A.; Melton, S.L.; Yao, C.K.; Gibson, P.R.; Halmos, E.P. Dietary management of adults with IBD—The emerging role of dietary therapy. Nat. Rev. Gastroenterol. Hepatol. 2022, 19, 652–669. [Google Scholar] [CrossRef]
  122. Dineen-Griffin, S.; Garcia-Cardenas, V.; Williams, K.; Benrimoj, S.I.; Leroyer, C. Helping patients help themselves: A systematic review of self-management support strategies in primary health care practice. PLoS ONE 2019, 14, e0220116. [Google Scholar] [CrossRef]
  123. Karam, M.; Chouinard, M.-C.; Poitras, M.-E.; Couturier, Y.; Vedel, I.; Grgurevic, N.; Hudon, C. Nursing Care Coordination for Patients with Complex Needs in Primary Healthcare: A Scoping Review. Int. J. Integr. Care 2021, 21, 16. [Google Scholar] [CrossRef]
  124. Westland, H.; Schröder, C.D.; De Wit, J.; Frings, J.; Trappenburg, J.C.A.; Schuurmans, M.J. Self-management support in routine primary care by nurses. Br. J. Health Psychol. 2018, 23, 88–107. [Google Scholar] [CrossRef]
  125. Coventry, T.H.; Maslin-Prothero, S.E.; Smith, G. Organizational impact of nurse supply and workload on nurses continuing professional development opportunities: An integrative review. J. Adv. Nurs. 2015, 71, 2715–2727. [Google Scholar] [CrossRef]
  126. Peasah, S.K.; Swart, E.C.S.; Huang, Y.; Kane-Gill, S.L.; Seybert, A.L.; Patel, U.; Manolis, C.; Good, C.B. Disease-Modifying Medications in Patients with Rheumatoid Arthritis in the USA: Trends from 2016 to 2021. Drugs Real World Outcomes 2024, 11, 241–249. [Google Scholar] [CrossRef]
  127. Gossec, L.; Molto, A.; Romand, X.; Puyraimond-Zemmour, D.; Lavielle, M.; Beauvais, C.; Senbel, E.; Flipo, R.-M.; Pouplin, S.; Richez, C.; et al. Recommendations for the assessment and optimization of adherence to disease-modifying drugs in chronic inflammatory rheumatic diseases: A process based on literature reviews and expert consensus. Jt. Bone Spine 2019, 86, 13–19. [Google Scholar] [CrossRef]
  128. Giacomelli, R.; Afeltra, A.; Alunno, A.; Baldini, C.; Bartoloni-Bocci, E.; Berardicurti, O.; Carubbi, F.; Cauli, A.; Cervera, R.; Ciccia, F.; et al. International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren’s syndrome)?: The Unmet Needs and the Clinical Grey Zone in Autoimmune Disease Management. Autoimmun. Rev. 2017, 16, 911–924. [Google Scholar] [CrossRef] [PubMed]
  129. Deodhar, A.; Mittal, M.; Reilly, P.; Bao, Y.; Manthena, S.; Anderson, J.; Joshi, A. Ankylosing spondylitis diagnosis in US patients with back pain: Identifying providers involved and factors associated with rheumatology referral delay. Clin. Rheumatol. 2016, 35, 1769–1776. [Google Scholar] [CrossRef] [PubMed]
  130. Pinto, A.J.; Roschel, H.; de Sá Pinto, A.L.; Lima, F.R.; Pereira, R.M.R.; Silva, C.A.; Bonfá, E.; Gualano, B. Physical inactivity and sedentary behavior: Overlooked risk factors in autoimmune rheumatic diseases? Autoimmun. Rev. 2017, 16, 667–674, Erratum in: Autoimmun. Rev. 2022, 21, 102928. https://doi.org/10.1016/j.autrev.2021.102928. [Google Scholar] [CrossRef] [PubMed]
  131. Mohapatra, A.; Patwari, S.; Pansari, M.; Padhan, S. Navigating Pain in Rheumatology: A Physiotherapy-Centric Review on Non-pharmacological Pain Management Strategies. Cureus 2023, 15, e51416. [Google Scholar] [CrossRef] [PubMed]
  132. Barukba, H.; Alnaimat, F. Rehabilitation in Rheumatic Diseases. Anti-Aging East. Eur. 2023, 2, 150–157. [Google Scholar] [CrossRef]
  133. Hon, S.; Ritter, R.; Allen, D.D. Cost-Effectiveness and Outcomes of Direct Access to Physical Therapy for Musculoskeletal Disorders Compared to Physician-First Access in the United States: Systematic Review and Meta-Analysis. Phys. Ther. 2021, 101, pzaa201. [Google Scholar] [CrossRef]
  134. Boger, J.; Quraishi, M.; Turcotte, N.; Dunal, L. The identification of assistive technologies being used to support the daily occupations of community-dwelling older adults with dementia: A cross-sectional pilot study. Disabil. Rehabil. Assist. Technol. 2013, 9, 17–30. [Google Scholar] [CrossRef]
  135. Roll, S.C.; Samantha, H.Y. (Re-) Defining Ergonomics in Hand Therapy: Applications for the Management of Upper Extremity Osteoarthritis. J. Hand Ther. 2022, 35, 400–412. [Google Scholar] [CrossRef]
  136. Norberg, E.-B.; Löfgren, B.; Boman, K.; Wennberg, P.; Brännström, M. A client-centred programme focusing energy conservation for people with heart failure. Scand. J. Occup. Ther. 2017, 24, 455–467. [Google Scholar] [CrossRef]
  137. Garvey, J.; Connolly, D.; Boland, F.; Smith, S.M. OPTIMAL, an occupational therapy led self-management support programme for people with multimorbidity in primary care: A randomized controlled trial. BMC Fam. Pract 2015, 16, 59. [Google Scholar] [CrossRef] [PubMed]
  138. Knight, A.; Vickery, M.; Faust, L.; Muscal, E.; Davis, A.; Harris, J. Childhood Arthritis and Rheumatology Research Alliance Investigators. Gaps in Mental Health Care for Youth with Rheumatologic Conditions: A Mixed Methods Study of Perspectives from Behavioral Health Providers. Arthritis Care Res. 2019, 71, 591–601. [Google Scholar] [CrossRef]
  139. Vanfleteren, L.E.G.W.; Spruit, M.A.; Wouters, E.F.M.; Franssen, F.M.E. Management of chronic obstructive pulmonary disease beyond the lungs. Lancet Respir. Med. 2016, 4, 911–924. [Google Scholar] [CrossRef] [PubMed]
  140. Betteridge, N.; Camilleri, C.; Stoyanoff, L.; Kopansky-Giles, D.; de Guzman, J.; Makri, S.; Mwaniki, L. What Do People Need? Best Pract. Res. Clin. Rheumatol. 2020, 34, 101567. [Google Scholar]
  141. Bruce, R.D.; Merlin, J.; Lum, P.J.; Ahmed, E.; Alexander, C.; Corbett, A.H.; Foley, K.; Leonard, K.; Treisman, G.J.; Selwyn, P. 2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living with HIV. Clin. Infect. Dis. 2017, 65, e1–e37. [Google Scholar] [CrossRef]
  142. Muscaritoli, M.; Imbimbo, G.; Jager-Wittenaar, H.; Cederholm, T.; Rothenberg, E.; di Girolamo, F.G.; Amabile, M.I.; Sealy, M.; Schneider, S.; Barazzoni, R.; et al. Disease-related malnutrition with inflammation and cachexia. Clin. Nutr. 2023, 42, 1475–1479. [Google Scholar] [CrossRef]
  143. Iregbu, S.; Spiers, J.; Duggleby, W.; Salami, B.; Schick-Makaroff, K. Nigerian Health Care Providers and Diabetes Self-Management Support: Their Perspectives and Practices. Qual. Health Res. 2022, 33, 92–105. [Google Scholar] [CrossRef]
  144. Daien, C.; Czernichow, S.; Letarouilly, J.-G.; Nguyen, Y.; Sanchez, P.; Sigaux, J.; Beauvais, C.; Desouches, S.; Le Puillandre, R.; Rigalleau, V.; et al. Dietary recommendations of the French Society for Rheumatology for patients with chronic inflammatory rheumatic diseases. Jt. Bone Spine 2022, 89, 105319. [Google Scholar] [CrossRef]
  145. Foster, H.E.; Minden, K.; Clemente, D.; Leon, L.; McDonagh, J.E.; Kamphuis, S.; Berggren, K.; van Pelt, P.; Wouters, C.; Waite-Jones, J.; et al. EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann. Rheum. Dis. 2017, 76, 639–646. [Google Scholar] [CrossRef]
  146. Overman, C.L.; Kool, M.B.; Da Silva, J.A.P.; Geenen, R. The prevalence of severe fatigue in rheumatic diseases: An international study. Clin. Rheumatol. 2015, 35, 409–415. [Google Scholar] [CrossRef]
  147. Dushnicky, M.J.; Har-Gil, E.S.; Lee, J.J.; Levy, D.M. Pediatric Rheumatology Care in the Canadian Context: A Qualitative Analysis of Care Providers. J. Rheumatol. 2025, 52, 498–504. [Google Scholar] [CrossRef] [PubMed]
  148. Herndon, S.; Kimball, J.; Ross, L.; Homann, S.; Faison, M.N.; Lee, Y.-L.A.; Marks, A.; Weinmann, S.C.; Maheswaranathan, M.; Leverenz, D.; et al. Top Ten Tips Palliative Care Clinicians Should Know About Rheumatology. J. Palliat. Med. 2025. [Google Scholar] [CrossRef] [PubMed]
  149. Xiang, L.; Low, A.H.L.; Leung, Y.Y.; Fong, W.; Lau, T.C.; Koh, D.R.; Yoon, S.; Thumboo, J. Development of START, a novel multimedia-based symptom appraisal tool for autoimmune rheumatic diseases. Rheumatology 2025, 64, 3334–3343. [Google Scholar] [CrossRef] [PubMed]
  150. Wulandari, W.; Zakiyah, N.; Rahayu, C.; Puspitasari, I.M.; Suwantika, A.A. Health-related quality of life in hypertensive patients with chronic kidney disease in low and middle-income countries. BMC Nephrol. 2025, 26, 34. [Google Scholar] [CrossRef]
  151. May, S.; Nordmann, G.; Gabb, F.; Boy, K.; Wagner, M.; Ohm, N.; Labinsky, H.; Knitza, J.; Kuhn, S.; Heinze, M.; et al. Between uncertainty and destiny: The patient journey in axial spondyloarthritis care from the perspectives of patients and their relatives. BMC Rheumatol. 2025, 9, 14. [Google Scholar] [CrossRef]
  152. Viswanathan, A.; Brahma, N.; Vimal, S. The future of autoimmune disease care: Merging genomic insights and imaging for enhanced prognosis in rheumatoid arthritis. Clin. Rheumatol. 2025, 44, 1863–1866. [Google Scholar] [CrossRef]
  153. Cerasoli, T.; Filardo, G.; Favero, A.; Rinaldi, V.G.; Di Maio, L.; Muccioli, G.M.M.; Zaffagnini, S. Injective Therapies for Managing Sacroiliac Joint Pain in Spondyloarthropathy: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 1294. [Google Scholar] [CrossRef]
  154. Flower, C.; Lau, C.S. Rheumatology education without borders—A global approach to basic instruction on the complex disease of SLE. Front. Lupus 2025, 3, 1540588. [Google Scholar] [CrossRef]
  155. Vieujean, S.; Jairath, V.; Peyrin-Biroulet, L.; Dubinsky, M.; Iacucci, M.; Magro, F.; Danese, S. Understanding the Therapeutic Toolkit for Inflammatory Bowel Disease. Nat. Rev. Gastroenterol. Hepatol. 2025, 22, 371–394. [Google Scholar] [CrossRef]
  156. Moore, C.M.; Pan, C.X.; Roseman, K.; Stephens, M.M.; Bien-Aime, C.; Morgan, A.C.; Ross, W.; Castillo, M.C.; Palathra, B.C.; Jones, C.A.; et al. Top Ten Tips Palliative Care Clinicians Should Know About Navigating the Needs of Adults with Intellectual Disabilities. J. Palliat Med. 2022, 25, 1857–1864. [Google Scholar] [CrossRef] [PubMed]
  157. Siddiqui, M.T.; Kasiraj, R.; Naseer, M. Medical Management of Ulcerative Colitis and Crohn’s Disease—Strategies for Inducing and Maintaining Remission. Surg. Clin. 2025, 105, 435–454. [Google Scholar] [CrossRef]
  158. Hammam, N.; El-Hadidi, T.; El-Hadidi, K.; Elsaman, A.; El-Bakry, S.A.; Nassr, M.; El-Saadany, H.M.; Mosad, D.; Nasef, S.I.; Selim, Z.I.; et al. International overview on juvenile-, adult- and elderly-onset rheumatoid arthritis: The age at disease onset as a fundamental determinant of clinical presentation. Clin. Rheumatol. 2025, 44, 979–988. [Google Scholar] [CrossRef]
  159. Liu, Y.Q.; Liu, Y.; Chen, Z.Y.; Li, H.; Xiao, T. Rheumatoid arthritis and osteoporosis: A bi-directional Mendelian randomization study. Aging 2021, 13, 14109–14130. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  160. Newton-John, T.R.O.; Cave, S.; Bean, D.J. Mental and Physical Well-Being of Partners of People Living with Chronic Pain: A Narrative Review. Int. J. Environ. Res. Public Health 2025, 22, 205. [Google Scholar] [CrossRef]
  161. So, H.; Chow, E.; Cheng, I.T.; Lau, S.-L.; Li, T.K.; Szeto, C.-C.; Tam, L.-S. Telemedicine for follow-up of systemic lupus erythematosus during the 2019 coronavirus pandemic: A pragmatic randomized controlled trial. J. Telemed. Telecare 2025, 31, 222–230. [Google Scholar] [CrossRef]
  162. Pfeuffer, N.; Hartmann, F.; Grahammer, M.; Simon, D.; Schuster, L.; Kuhn, S.; Krönke, G.; Schett, G.; Knitza, J.; Kleyer, A. Early detection of rheumatoid arthritis through patient empowerment by tailored digital monitoring and education: A feasibility study. Rheumatol. Int. 2025, 45, 43. [Google Scholar] [CrossRef]
  163. West, C.; Usher, K.; Foster, K.; Stewart, L. Chronic pain and the family: The experience of the partners of people living with chronic pain. J. Clin. Nurs. 2012, 21, 3352–3360. [Google Scholar] [CrossRef] [PubMed]
  164. Bidoli, C.; Pegoraro, V.; Mas, F.D.; Bagnoli, C.; Bert, F.; Bonin, M.; Butturini, G.; Cobianchi, L.; Cordiano, C.; Minto, G.; et al. Virtual hospitals: The future of the healthcare system? An expert consensus. J. Telemed. Telecare 2025, 31, 121–133. [Google Scholar] [CrossRef]
  165. Shakeel, L.M.; Shaukat, A.M.; Khaliq, N.M.; Kashif, A.M.; Mujeeb, A.M.; Adnan, Z.M.; Taj, J.M.; Akilimali, A. Rheumatoid arthritis: A comprehensive overview of genetic markers, emerging therapies, and personalized medicine. Ann. Med. Surg. 2025, 87, 696–710. [Google Scholar] [CrossRef]
  166. Alsararatee, H.H. Lipodermatosclerosis: From Pathophysiology to Treatment. Br. J. Nurs. 2025, 34, 134–139. [Google Scholar] [CrossRef]
  167. Nordkamp, A.; Midtgaard, J.; de Thurah, A.; Glintborg, B.; Aadahl, M.; Cromhout, P.F.; Esbensen, B.A. “Excluding Myself from What I Need the Most”: Experiences of Loneliness in People with Inflammatory Arthritis—A Qualitative Study. Int. J. Rheum. Dis. 2025, 28, e70041. [Google Scholar] [CrossRef]
  168. Kim, Y.; Kim, B.; Park, J.S.; Rajaguru, V.; Chang, H.J.; Lee, S.G.; Kim, T.H. Associations of Healthcare Utilization and Health Expenditures in Older Adults with Osteoarthritis: Korean Health Panel Survey Study. Int. J. Rheum. Dis. 2025, 28, e70099. [Google Scholar] [CrossRef]
  169. Mocanu, V.; Barber, C.E.; McLane, P.; Chomistek, K.; Davidson, E.; Elliott, M.J.; Hildebrandt, C.; Katz, S.; Lin, K.; McQuitty, S.; et al. Potentially Avoidable Emergency Department Utilization by Persons with Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: A Population-Based Cohort Study. J. Rheumatol. 2025, 52, 243–250. [Google Scholar] [CrossRef]
  170. Manolis, A.S.; Tzioufas, A.G. Cardio-Rheumatology: Two Collaborating Disciplines to Deal with the Enhanced Cardiovascular Risk in Autoimmune Rheumatic Diseases. Curr. Vasc. Pharmacol. 2020, 18, 533–537. [Google Scholar] [CrossRef] [PubMed]
  171. Almalag, H.M.; Alosaimi, N.; Alqahtani, R.; Alharbi, R.; Alarfaj, A.S.; Omair, M.A.; Bedaiwi, M.; Qurtas, I.; Almaghlouth, I.; Alsabhan, J.F.; et al. Exploring Patient Activation and Compliance in Patients with Different Rheumatological Disorders. Healthcare 2025, 13, 71. [Google Scholar] [CrossRef]
  172. Dupont, D.; Brinkmöller, S.; Carter, S.; Wensing, M.; Straßner, C.; Engeser, P.; Poß-Doering, R. Exploring Physician and Patient Perspectives on Expectations and Role Models Towards Chronic Pain Treatment in General Practice: A Qualitative Cross-Sectional Study. Healthcare 2025, 13, 187. [Google Scholar] [CrossRef]
  173. Guerrero Aznar, M.D.; Villanueva Guerrero, M.D.; Beltrán García, M.; Hernández Cruz, B. Specific Composition Diets and Improvement of Symptoms of Immune-Mediated Inflammatory Diseases in Adulthood—Could the Comparison Between Diets Be Improved? Nutrients 2025, 17, 493. [Google Scholar] [CrossRef]
  174. Salaffi, F.; Farah, S.; Di Donato, E.; Sonnati, M.; Filippucci, E.; De Angelis, R.; Gabbrielli, F.; Di Carlo, M. Remote-Customized Telecontrol for Patients with Rheumatoid Arthritis: The iARPlus (Innovative Approach in Rheumatology) Initiative. J. Pers. Med. 2025, 15, 30. [Google Scholar] [CrossRef]
  175. Afzal, F.; Adnan, S.; Fatima, I.; Naeem, W.; Arshad, T.; Shahzad, F.; Khalid, M. Evaluation of Quality of Life (QOL), Medication Compliance and Correlation with Socio-Economic Variables in Patients with Rheumatoid Arthritis in Sialkot, Punjab, Pakistan. Res. J. Soc. Aff. 2025, 3, 181–194. [Google Scholar]
  176. Cuenca-Zaldívar, J.N.; del Corral-Villar, C.; García-Torres, S.; Araujo-Zamora, R.; Gragera-Peña, P.; Martínez-Lozano, P.; Sánchez-Romero, E.A. Fourteen-Year Retrospective Cohort Study on the Impact of Climatic Factors on Chronic Musculoskeletal Pain: A Spanish Primary Care Analysis. Int. J. Rheum. Dis. 2025, 28, e70125. [Google Scholar] [CrossRef]
Figure 1. Relationship between nursing interventions and quality of life.
Figure 1. Relationship between nursing interventions and quality of life.
Healthcare 13 01691 g001
Table 1. Types of Nursing Interventions.
Table 1. Types of Nursing Interventions.
Ref.Study TypeFocused InterventionTargeted DomainKey Findings/Outcomes
[81]ReviewNon-pharmacological pain relief (e.g., TENS, cold/heat)Pain ManagementTENS, thermal therapies reduce chronic rheumatic pain; effective as an adjuvant.
[82]Narrative reviewIntegrated treatment approachesFunctional Rehabilitation and EducationHighlights the importance of nurse-led interventions and self-care support.
[83]ReviewPsychological impact and affective disturbancePsychosocial SupportEmphasizes the link between emotional distress and disease flares in RA.
[84]ExperimentalTargeted drug delivery (nanoparticles)Pain and Disease ManagementSupports precise medication interventions; nurses monitor systemic reactions.
[85]ObservationalLupus care post-COVIDPatient Education and MonitoringNurses are involved in organ system monitoring and risk communication.
[86]Systematic ReviewNursing-sensitive outcomesMultiple DomainsValidates measurable outcomes in RA care: pain, fatigue, function.
[87]Randomized Controlled Trial (COMEDRA)Nurse-led comorbidity and self-monitoringPatient EducationDemonstrates improved patient adherence and disease awareness.
[88]ReviewSafety of anti-rheumatic drugsPharmacological ManagementNurses play a role in monitoring adverse effects and compliance.
[89]Clinical GuidanceEarly arthritis managementPain ManagementHighlights the importance of early intervention, nurse involvement in triage.
[90]ReviewNonpharmacological treatment in RAPain ManagementAdvocates combine TENS, exercise, and counselling.
[91]Clinical ReviewPain management without medicationPain and PsychosocialIntegrates CBT, relaxation, and physical therapies.
[92]Clinical GuidelinesSjögren’s management incl. fatiguePain and PsychosocialRecommends multidisciplinary strategies; nurses lead fatigue education.
[93]Book chapterChronic pain modalitiesPain ManagementPresents evidence on massage, manual therapies in chronic pain.
[94]ReviewPsycho-neuro-immunological approachPsychosocial and FunctionalSuggests holistic nurse-led care improves immune balance.
[95]ExperimentalExercise and fatigue in rheumaticsFunctional RehabilitationDemonstrates that exercise reduces fatigue and improves mobility.
Table 2. Evidence on the effectiveness of healthcare interventions for rheumatic disease patient care.
Table 2. Evidence on the effectiveness of healthcare interventions for rheumatic disease patient care.
Ref.Study TypeFocus of InterventionKey FindingsImplications for Nursing Practice
[96]Systematic ReviewNursing interventions for patients on biologicsImproved adherence and disease controlSupports nurse involvement in biologic therapy management
[97]Expert ConsensusNon-pharmacological care for Psoriatic ArthritisEnhanced physical function, reduced symptomsNurses should promote physical therapy and patient counselling
[98]ReviewNon-pharmacological, non-surgical OA treatmentSignificant symptom relief through conservative careValidates nursing-led interventions for OA
[99]Randomized Controlled TrialJoint protection and physical activity trainingIncreased self-efficacy and mobilityEncourages an active nurse role in RA education and rehabilitation
[100]Integrative ReviewRA patient experiencesIdentified educational and emotional needsHighlights personalised education by nurses
[101]Mixed-Methods Systematic ReviewOccupational therapy impact in RABoosted self-management and daily functionAdvocates nurse-OT collaboration for holistic care
[102]Narrative ReviewEULAR-based nursing rolesAligned care improves patient outcomesReinforces evidence-based nursing practice standards
[103]Observational StudyRehab needs in inflammatory rheumatic diseasesNotable gaps in nursing-led rehabilitationNurses need to expand rehab service coordination
[104]Multicentre CohortFollow-up adherence in musculoskeletal rehabPositive link between follow-up and self-managementUnderlines the importance of sustained nursing support
[105]Systematic ReviewMobile health apps for self-managementDigital tools enhance treatment adherenceNurses should integrate mHealth tools in care plans
[106]Cross-sectional StudyNurse roles in disease managementBroad scope: education, monitoring, advocacyCalls for expanded training and autonomy for nurses
[107]Literature ReviewImplementation of EULAR recommendationsEffective disease monitoring and counsellingConfirms the necessity of guideline-informed nursing
[108]Randomized Controlled Trial (Crossover)Anti-inflammatory diet in RALowered disease activity with dietary supportValidates nurse-led nutrition interventions
[109]Systematic ReviewDiet + omega-3 in RAModerate pain and stiffness reductionSupports the inclusion of dietitians in nursing care models
[110]Intervention Development StudyINSELMA: Interdisciplinary nurse-led modelImproved engagement and self-managementShowcases a model for advanced nurse coordination
[111]EULAR Guideline UpdateNursing in chronic arthritis managementClear role definitions and practice standardsFoundation for structured, effective nursing roles
Table 3. Disease-Specific Findings and Nursing Implications in Rheumatic Conditions.
Table 3. Disease-Specific Findings and Nursing Implications in Rheumatic Conditions.
Study (Citation)Disease FocusMain FindingsNursing Intervention Implications
[112]General RMDsEmphasises adherence as a core challenge in chronic rheumatic careNurses play a key role in adherence counselling, screening for non-compliance, and promoting follow-up routines
[113]SystemicLupus Erythematosus (SLE)Multidisciplinary care improves outcomes and quality of life in SLENurses coordinate interdisciplinary teams, monitor multi-organ complications, and support fatigue and mental health
[114]Osteoarthritis (OA)Nurse-led CBT significantly reduced pain and improved copingNurses can deliver behavioral pain management programs to improve QoL
[115]Inflammatory arthritisStrong support for structured patient education in IANurses are central in educational planning, empowering patients to self-manage and monitor disease activity
[116]Inflammatory arthritisPsychological factors influence disease burdenNursing support should include emotional screening and tailored mental health referrals
[117]Autoimmune rheumatic diseasesPTSD and trauma are linked to flare-ups and disease severityNurses should assess trauma history and integrate stress-reduction interventions
[118]Rheumatoid arthritis (ROA), Osteoarthritis, Systemic Lupus ErythematosusNational data confirm a high burden on mental and physical healthNurses must adopt holistic strategies, addressing function, fatigue, and mental well-being
[119]Inflammatory arthritisRehabilitation is often underused despite evidenceNurses can advocate for rehab referrals, deliver mobility training
[120]General rheumatologyNurses are essential in outpatient care coordination and monitoringSupports nurse-led clinics, continuous patient follow-up, and care continuity
[121,122]Rheumatoid arthritis, Inflammatory Bowel Disease (IBD)Diet impacts inflammatory markers and energy levelsNurses assist in nutritional planning and dietary education tailored to comorbidities
[123]General RMDsEffective self-management support improves engagementNurses should use structured self-management protocols
[124]Chronic complex needsEffective coordination improves care for patients with comorbiditiesNurses act as care navigators, ensuring integration between rheumatology, primary care, and rehab
[125]Chronic diseasesRegular nurse-led support boosts treatment adherenceValidates the use of nurse-led self-management clinics in routine care
[126]General nursingWorkload limits access to continuous development
Trends show an increase in DMARDs and biologics
Overburdened nurses may lack resources to stay updated, highlighting the need for professional development support
Nurses support medication monitoring, educate patients on biologic safety, and adherence
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Verga, G.I.; Baltă, A.A.Ș.; Ciortea, D.-A.; Petrea, C.L.; Șerban, M.; Matei, M.N.; Gurău, G.; Șuța, V.-C.; Voinescu, D.C. Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies. Healthcare 2025, 13, 1691. https://doi.org/10.3390/healthcare13141691

AMA Style

Verga GI, Baltă AAȘ, Ciortea D-A, Petrea CL, Șerban M, Matei MN, Gurău G, Șuța V-C, Voinescu DC. Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies. Healthcare. 2025; 13(14):1691. https://doi.org/10.3390/healthcare13141691

Chicago/Turabian Style

Verga (Răuță), Gabriela Isabela, Alexia Anastasia Ștefania Baltă, Diana-Andreea Ciortea, Carmen Loredana Petrea (Cliveți), Mariana Șerban (Grădinaru), Mădălina Nicoleta Matei, Gabriela Gurău, Victoria-Cristina Șuța, and Doina Carina Voinescu. 2025. "Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies" Healthcare 13, no. 14: 1691. https://doi.org/10.3390/healthcare13141691

APA Style

Verga, G. I., Baltă, A. A. Ș., Ciortea, D.-A., Petrea, C. L., Șerban, M., Matei, M. N., Gurău, G., Șuța, V.-C., & Voinescu, D. C. (2025). Healthcare Interventions in the Management of Rheumatic Diseases: A Narrative Analysis of Effectiveness and Emerging Strategies. Healthcare, 13(14), 1691. https://doi.org/10.3390/healthcare13141691

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop